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Abstract
Acute bacterial skin and skin structure infections (ABSSSI) are common infections
within the local community, and they result in higher morbidity and health care costs.
While risk factors for skin and soft tissue infections have been previously evaluated, risk
factors associated with secondary bloodstream infections (BSI) has not been investigated,
especially in an intercity patient population with limited health care resources. In this
case control investigation, 392 patients consisting of 196 cases (ABSSSI + BSI) and 196
controls (ABSSSI) were investigated to determine risk for BSI. Both sociodemographic
and underlying conditions were evaluated. According to bivariate analysis of cases and
controls, individuals with ABSSSI + BSI were significantly older (p < 0.001), more often
male (p = 0.008), and had a higher percentage of abnormal symptoms, such as elevated
temperature, white blood cell count, and acute renal failure on hospital admission (p <
0.001). Individuals with ABSSSI + BSI also had a higher percentage of chronic renal
failure (p = 0.002), diabetes (p = 0.005), congestive heart failure (p = 0.012), intravenous
drug use (p =0.012), and a history of prior hospitalization (p < 0.001). Several of these
factors remained statistically significant by logistic regression analysis, such as male
gender aOR of 1.85, 95% CI 1.11-3.66; acute renal failure aOR 2.08, 95% CI 1.18-3.67;
intravenous drug use aOR 4.38, 2.22-8.62; and prior hospitalization aOR 2.41, 95% CI
1.24-4.93. This study contributes to positive social change by identifying patient
characteristics that are associated with ABSSSI-related BSI, thus providing health care
providers the ability to improve patient outcomes in this underserved patient population.
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Chapter 1: Introduction to the Study
Introduction
Acute bacterial skin and skin structure infections (ABSSSI) are complicated skin
and soft tissue infections that are caused by bacterial pathogens including resistant
bacterial organisms, such as methicillin-resistant Staphylococcus aureus (MRSA) that
were previously susceptible to a variety of common antibiotics. The Food and Drug
Administration (FDA, 2013) issued new nomenclature in an effort to define complicated
skin and skin structures infections. ABSSSI are complicated skin and skin structure
infections that generally require hospitalization and parenteral antibiotics and include the
diagnosis of cellulitis/erysipelas, wound infection, major cutaneous abscess with an
accompanying redness, or an induration or edema that extends to a minimum lesion
surface area of 75cm2 (Moran, Abrahamian, Lovecchio, & Talan, 2013). ABSSSI are
one of the most common infections in both the community and hospital settings (Amin et
al., 2014; Pallin et al., 2008; Pollack et al., 2015). There are a variety of complications
that can occur secondary to ABSSSI. One of the most severe complications is
bloodstream infection (BSI; Lipsky, Kollef, et al., 2010; Suaya, Eisenberg, Fang, &
Miller, 2013; Tattevin et al., 2012). While risk factors for ABSSSI have been well
documented, there is limited information regarding risk for BSI in patients with ABSSSI.
The purpose of this study was to evaluate the risk factors associated with BSI in
patients with ABSSSI who reside in intercity Detroit. Individuals living in the intercity
with low socioeconomic status are likely to have poor access to health care resources and
may be at a higher risk for BSI secondary to ABSSSI; this population has not been well-
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studied. Evaluating this patient population for risk factors for BSI may lead to
improvement in patient outcomes and potentially reduce the risk for BSI. This study may
lead to positive social change because the population that was evaluated has been
previously shown to be at high risk for complications and increased infection severity.
The background for the study, along with supporting evidence from the literature,
is reviewed in Chapter 1. The background section is followed by the problem statement,
the purpose of the study, the dependent and independent variables, and the research
hypotheses. Next, the theoretical and conceptual framework is discussed followed by the
nature of the study. Definitions of the primary outcome variables, study assumptions,
and the scope and delimitations are also provided in this chapter. Lastly, in this chapter, I
discuss the study limitations, significance of the study, and potential implications for
social change consistent with the scope of the study.
Background
Skin and skin structure infection (SSSI) is a disease of the skin and is defined as
an infection of the epidermis, dermis, and/or deeper subcutaneous tissues (Dryden, 2010).
The Infectious Diseases Society of America classify SSSI into a mild infection consisting
of cellulitis/erysipelas without a purulent focus; moderate infection consisting of
cellulitis/erysipelas and systemic signs of infection; and severe infections that includes
failure to respond to previous antibiotic therapy, systemic signs of infection, infection in
immunocompromised patients and deeper infections involving bullae, necrotizing
fasciitis, and evidence of organ dysfunction (as cited in Stevens et al., 2014). The most
common SSSIs types are cellulitis and erysipelas, which are the diffuse spreading skin
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infections that are not associated with a suppurative focus. Abscesses are also common
and consist of a collection of pus within the dermis and deeper fascia and are often
associated with inflammation and purulent discharge (Amin et al., 2014).
The number of patients diagnosed with SSSIs has been steadily increasing in the
United States over the last decade (Amin et al., 2014; Itani et al., 2011; Tattevin et al.,
2012). This increase in SSSIs has coincided with rising hospital admissions and
complications including secondary bone and joint infections, amputations, and BSI (Ray,
Suaya, & Baxter, 2013a; Suaya et al., 2013). BSIs are considered one of the most severe
complications of ABSSSI as BSI carries a significant risk for morbidity and mortality
(Lipsky, Kollef, et al., 2010; van Hal et al., 2012). The most common bacterial pathogen
associated with BSI secondary to ABSSSI is Staphylococcus aureus (S. aureus). S.
aureus are now commonly resistant to penicillin and other beta-lactam antibiotics making
it more challenging for clinicians to appropriately treat these infections. These organisms
are collectively referred to as methicillin-resistant S. aureus (MRSA) and make up more
than 50% of all S. aureus strains associated with infections encountered in the community
(Ray, Suaya, & Baxter, 2012).
Community-associated MRSA infections (CAMRSA) are associated with
ABSSSI, and the prevalence of these infections has increased over the last decade in the
United States (Moran et al., 2006; Pallin et al., 2008). In a retrospective study of
133,450, Ray et al. (2012) evaluated S. aureus isolates obtained from patients with
infections from a large U.S. integrated health care organization over the years 1998-2009.
During this time period, the prevalence of MRSA infections increased from 9% to 49%
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between the years of 1998 until 2005 and decreased slightly from 49 to 43% between
2006 and 2009 (Ray et al., 2012). This overall increase in MRSA was most often seen in
BSI specimens and was most pronounced in individuals who were 18-49 years of age and
African Americans (Ray et al., 2012). The largest increase in MRSA was observed from
community-associated infections, and the increase in MRSA was disproportionately
higher in African American and Hispanic American patients compared to European
American patients (Ray et al., 2012). In addition, after adjusting for other demographic
factors, Ray et al. found that that African Americans and individuals of low
socioeconomic status were at increased risk of MRSA infection (Ray et al., 2012). The
rise in MRSA infections over the last 10-15 years was largely due to the increase in
CAMRSA across the United States (Moran et al., 2013). While the relationship between
CAMRSA as and ABSSSI has been described, the relationship between CAMRSA and
BSI has not been well characterized. In an effort to evaluate this relationship, Tattevin et
al. (2012) evaluated risk factors and outcomes for 549 patients with BSI caused by
epidemic MRSA strains of which 55% were CAMRSA. Although the rates of mortality
between MRSA and CAMRSA strains were similar, two risk factors for CAMRSA BSI
were identified: concurrent SSTI and the use of antibiotics within the previous 30 days
(Tattevin et al., 2012). Interventions that could reduce SSTI caused by CAMRSA could
help to reduce the prevalence and severity of CAMRSA BSI (Tattevin et al., 2012).
A gap in knowledge exists and further characterization of patients who have
ABSSSI is warranted to determine the risk factors associated with BSI. In addition, there
is limited to no information on the relationship of ABSSSI, BSI, and socioeconomic
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status. Information derived from this study may lead to improved outcomes in a patient
population at a higher risk for complications secondary to ABSSSI associated BSI.
Problem Statement
ABSSSI are one of the most common infections encountered in community and
health care settings (Dryden, 2010; Edelsberg et al., 2009). These infections are
associated with many complications including bloodstream infections (Bassetti et al.,
2012; Klevens et al., 2007). Patients with serious ABSSSI require hospitalization. Of
those hospitalized, cellulitis and abscess are the most common types of ABSSSI and
accounted for as many as 597,000 admissions or 1.5% of all hospitalizations in the
United States in 2006 (Itani et al., 2011). S. aureus is one of the most common bacterial
pathogens that cause ABSSSI (Dryden, 2009). The rate of CAMRSA as a cause of
increased ABSSSI has increased, accounting for over 3 million annual emergency
department visits and a prevalence of over 80% in some areas of the United States
(Mistry et al., 2014; Pallin et al., 2008).
Certain patient populations may be at higher risk for infectious disease
complications and poor treatment outcomes (Holman et al., 2011; Khabbaz, Moseley,
Steiner, Levitt, & Bell, 2014; Moore, Keruly, & Bartlett, 2012). For example, the rates of
invasive community-associated MRSA infections are higher among African Americans
compared to European Americans and in individuals with lower socioeconomic status in
the United States (Klevens et al., 2007). In addition, investigators evaluating African
Americans of low socioeconomic status have reported a higher rate of persistent infection
burden, higher hospital readmission rates, and increased risk of infection complications
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including sepsis severity (Acosta et al., 2013; Morris et al., 2014; Zajacova, Dowd, &
Aiello, 2009).
One of the worst worrisome complications of ABSSSI is bacteremia (Bassetti et
al., 2012; Lipsky, Tabak, et al., 2010). Bacteremia secondary to ABSSSI was previously
reported as infrequent. However, bacteremia can occur in up to 20% of patients with
severe ABSSSI (Lipsky, Tabak, et al., 2010). Because bacteremia is associated with
higher rates of mortality, several investigators have attempted to identify patient
characteristics that are associated with bacteremia in patients with ABSSSI (Bassetti et
al., 2012; Lipsky, Kollef, et al., 2010; Shurland, Zhan, Bradham, & Roghmann, 2007).
However, risk factors for bacteremia, including measures of severity of infection, have
not been evaluated in African American patients with ABSSSI and low socioeconomic
status in an urban setting. Therefore, this study was useful in addressing a gap in
knowledge in the current literature regarding this patient population.
Purpose of the Study
The purpose of this study was to evaluate the health outcomes of patients with
low socioeconomic status in an urban city environment who had ABSSSI-related S.
aureus BSI infection. The primary aim of this investigation was to characterize and
determine the risk factors for patients with ABSSSI with concomitant BSI compared to
patients with ABSSSI alone admitted to the Detroit Medical Center and Henry Ford
Hospital in Detroit, Michigan. A secondary aim was to determine whether race/ethnicity
impacted severity of disease in patients with ABSSSI-associated BSI. While limited
information is available regarding the risk for ABSSSI among minority patients, there is
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no information regarding the risk for ABSSSI with concomitant BSI in this patient
population (Lipsky, Kollef, et al., 2010; Ray, Suaya, & Baxter, 2013b; Suaya et al., 2013;
Tattevin et al., 2012). To address this gap, a quantitative methods approach was
employed. Assessments were carried out via a case-control study design. The cases
consisted of patients admitted to the hospital and diagnosed with ABSSSI and S. aureus
BSI. The controls were comparable to cases that were admitted to the hospital for the
diagnosis of ABSSSI, but did not have associated BSI. The dependent variable was
ABSSSI with BSI. Additional dependent variables consisted of rates of mortality, length
of hospital stay, and secondary complications. The independent variables that were
believed to have an impact on whether a patient had ABSSSI or ABSSSI with bacteremia
included age, race/ethnicity, diabetes, cardiovascular disease, renal failure, recent
hospitalization, recent MRSA infection, socioeconomic status, alteration in temperature
and white blood cell count, and receipt of antibiotics in the past 30 days (Lipsky, Kollef,
et al., 2010; Tattevin et al., 2012). It was anticipated that characteristics identified by this
investigation would assist health care providers in improving patient outcomes in this
underserved population. The secondary outcome variable was the degree of disease
severity among patients with ABSSSI associated BSI. Disease severity was based on
number and type of surgical interventions. Covariate variables were the level of income
and education. Identifications of these factors can lead to recommendations and
prevention interventions to improve the health outcomes of patients with ABSSSI in an
urban environmental setting.
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Research Questions and Hypothesis
This study was designed to answer the following research questions:
RQ1. Are there significant differences in clinical and socioeconomic factors
between patients with ABSSSI and ABSSSI with BSI in intercity Detroit?
Subquestions for RQ1 were the following:
1.

Are there significant differences in the distribution of race/ethnicity
between patients with ABSSSI and patients with ABSSSI- associated
BSI?

2.

Are there significant differences in age between patients with ABSSSI and
patients with ABSSSI-associated BSI?

3.

Are there significant differences in the distribution of gender between
patients with ABSSSI and patients with ABSSSI-associated BSI?

4.

Are there significant differences in education between patients with
ABSSSI and patients with ABSSSI-associated BSI?

5.

Are there significant differences in income levels between patients with
ABSSSI and patients with ABSSSI-associated BSI?

6.

Are there significant differences in insurance status between patients with
ABSSSI and ABSSSI-associated BSI?

7.

Is the presence of a comorbid condition, namely diabetes, renal failure, or
cardiovascular disease, hepatic diseases, intravenous drug use (IVDU),
paraplegia, HIV/AIDS, immunosuppression (steroids, radiation,
chemotherapy) associated with ABSSSI-associated BSI?
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8.

Is alteration of temperature and white blood cell count at baseline
associated with ABSSSI-related BSI?

9.

Is a recent hospitalization (i.e., within the last 180 days of the present
hospitalization) associated with ABSSSI-related BSI?

10.

Is a recent hospitalization for MRSA or MSSA infection (i.e., within the
last 60 days of the present hospitalization) associated with ABSSSIassociated BSI?

11.

Is receipt of an antibiotic within the last 30 days associated with ABSSSIrelated BSI?

Ho1: There are no differences in sociodemographic and clinical factors between
patients with ABSSSI and ABSSSI-associated BSI.
Ha1: Patients with ABSSSI have different sociodemographic and clinical factors
compared to patients with ABSSSI-associated BSI.
RQ2. Is race/ethnicity associated with disease severity (based upon surgical
interventions [e.g., incision and drainage, wound debridement, amputation]) among
patients with ABSSSI-related BSI?
Ho2: Race/ethnicity associated with disease severity (based upon surgical
interventions, e.g., incision and drainage, wound debridement, amputation, shock or
admission to the intensive care unit [ICU]) is not different between patients with ABSSSI
and ABSSSI-associated BSI.
Ha2: Race/ethnicity associated with disease severity (based upon surgical
interventions [e.g., incision and drainage, wound debridement, amputation, shock, or
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admission to the ICU]) is different between patients with ABSSSI and ABSSSIassociated BSI.
Theoretical and Conceptual Framework
The theoretical framework for this study was the web of causation (Krieger,
1994). The web of causation conceptual framework is used to explain the association
between events, the causal agent, and the affected entity. The web of causation includes
a link between a preceding event and a subsequent outcome. The web of causation
theorists focus on the etiology and provide a process and an explanation for the outcome
of interest (Aschengrau, 2008; Krieger, 1994). The cause is a factor that plays a role in
the disease development. A disease that develops within a population can be related to
many different factors including genetic defects, disease causing pathogens, and social
and behavioral differences or environmental factors (Aschengrau, 2008; Center for
Disease Control and Prevention [CDC], 2012; Schneider, 2011). The web of causation
was used in this investigation to explore the relationship between the patient
characteristics and the targeted outcome variables between individuals with ABSSSI and
ABSSSI-associated BSI. This framework formed the basis for evaluating the differences
and similarities between patients with ABSSSI and ABSSSI-associated BSI for
characteristics including race/ethnicity; age; gender; medical insurance status; and
comorbidities, such as diabetes, renal failure, and cardiovascular diseases. In addition, I
measured the severity of illness by surgical intervention and complications. I explain the
web of causation and its relationship to this study further in Chapter 2.
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Nature of the Study
A quantitative, case-control study design was chosen to address the primary
research questions in this study. Case-control designs are retrospective investigations
(Hebel, 2006) that are appropriate study designs for evaluating risk factors for patients
with ABSSSI versus those with ABSSSI with BSI. Risk factors for BSI in patients with
ABSSSI hospitalized for skin and soft tissue infections have been previously identified
(Lipsky, Kollef, et al., 2010; Suaya et al., 2013). Although identifying social and
personal factors that could act as potential treatment barriers are suggested to ensure a
successful patient outcome, risk factors for patients with ABSSSI-associated BSI with
low socioeconomic status have not been evaluated (Bagger, Zindrou, & Taylor, 2004;
Itani et al., 2011; Klevens et al., 2007; Pollack et al., 2015; Ray et al., 2012).
The patient population included in this study was recruited from the Detroit
Medical Center and Henry Ford Hospital. The Detroit Medical Center is made up of nine
hospitals of which five are located in midtown Detroit Michigan. These hospitals service
a large group of individuals residing in intercity Detroit Michigan. The Henry Ford
Hospital is a major medical center that services a large portion of the population of
Detroit.
The primary outcome variable was ABSSSI-associated BSI. The secondary
outcome variable was disease severity, which was measured on number and type of
surgical interventions. The independent variables evaluated included age; gender;
race/ethnicity; educational level; income; medical insurance status; comorbid conditions
including diabetes, renal failure, and cardiovascular disease, and recent hospitalization
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defined as hospital contact within the last 180 days; and MRSA infection within the last
60 days. Descriptive statistics were used to characterize controls and cases. Continuous
variables were compared by a student t test if normally distributed and Mann-Whitney U
test if the normality assumption is not met. Categorical variables were evaluated using
chi-square or, as necessary, a two-tailed Fisher’s exact test. Multivariable analysis was
performed using multiple logistic regression models.
Definition of Terms
Acute bacterial skin and skin structure infections (ABSSSI): ABSSSIs are skin
infections that include cellulitis/erysipelas, wound infection, and major cutaneous
abscess. The lesion is also defined by size with a minimum surface area of 75 cm2.
ABSSSI excludes burn and diabetic foot infections. ABSSSI are caused by bacterial
pathogens and are commonly caused by Staphylococcus aureus including methicillinresistant strains and Streptococcus pyogenes. Less common bacterial strains include
other Streptococcus species, Enterococcus faecalis, and gram-negative bacteria (Pollack
et al., 2015).
Bloodstream infection (BSI): Viable bacteria in the bloodstream with the presence
of clinical symptoms that are associated with a high degree of morbidity and mortality
(del Rio, Cervera, Moreno, Moreillon, & Miro, 2009). Complicated bloodstream
infection is defined as persistent positive blood cultures obtained 48-96 hours after initial
blood cultures, persistent fever at 72 h, and skin lesions suggestive of systemic infection
(Corey, 2009). Uncomplicated bloodstream infection is defined as a negative blood
culture secondary to removal of an intravenous catheter, defervescence within 72 hours,
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no signs of infective endocarditis, absences of prosthetic medical devices, and no
symptoms of metastatic infection (Fowler et al., 2003).
Community-associated methicillin-resistant Staphylococcus aureus (CAMRSA):
CAMRSA strains are S. aureus strains isolated from patients in the community that are
susceptible to most antibiotics but resistant to the beta-lactam antibiotics. CAMRSA
strains are associated with skin and soft tissue infections. By definition, CAMRSA
infections occur in patients from the community with no known health care risk factors
(Klevens et al., 2007; Maree, Daum, Boyle-Vavra, Matayoshi, & Miller, 2007; Pallin et
al., 2008).
Complicated skin and soft tissue infections: The most extreme form of skin and
soft tissue infection that often requires surgical intervention and encompasses a number
of complications and comorbidities including neutropenia, tissue necrosis, skin ischemia
burns, and insect and animal bites (Dryden, 2010).
Methicillin-resistant Staphylococcus aureus (MRSA): MRSA are S. aureus
bacterial strains that are resistant to beta-lactam antibiotics and have been shown to be
associated with a higher rate of morbidity and mortality than methicillin-susceptible
strains. These strains are often referred to multidrug resistant S. aureus because besides
beta-lactams, these organisms are typically resistant to a variety of nonbeta lactam
antibiotics. MRSA infections are usually associated with a variety of health care risk
factors (Gordon & Lowy, 2008; Klevens et al., 2007).
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Methicillin-susceptible Staphylococcus aureus (MSSA): MSSA are S. aureus
bacterial strains that are susceptible to beta-lactam antibiotics and typically susceptible to
a wide variety of nonbeta lactam antibiotics (Dryden, 2009).
Secondary bloodstream infection: The CDC (2015) stated that the primary site of
infection may have seeded the bloodstream secondarily. The patient has a recognized
pathogen cultured from one or more blood cultures and has at least one of the following
signs or symptoms: fever (> 38.00 C), chills, or hypotension and the organism cultured
from the blood is not related to an infection at another site (CDC, 2015).
Skin and skin structure infections (SSSI): SSSIs are described as both
uncomplicated and complicated infections. Uncomplicated SSSIs include superficial
infections, such as cellulitis, simple abscesses, furnucles, and impetigo. Uncomplicated
SSSIs can often be treated with surgical intervention or antibiotics. Complicated SSSIs
are infections involving deeper soft tissues that require significant surgical intervention.
These patients usually have concomitant underlying comorbidities that may complicate
the response to therapy (Itani et al., 2011).
Skin and soft tissue infections (SSTIs): SSTIs are microbial invasions of the
epidermidis, dermis, and subcutaneous tissues resulting in inflammatory response and
infection (Dryden, 2009).
A more detailed description of the variables and how they will be analyzed can be
found in Chapter 3.
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Assumptions
One of the primary assumptions of this investigation was that the prevalence of
individuals with ABSSSI with BSI who reside in urban Detroit will be adequate enough
after exclusions criteria are applied to complete the required sample size needed for the
study. In addition, I assumed that the subject controls of patients with ABSSSI without
BSI were representative of the same urban Detroit population from which patients with
ABSSSI and BSI were collected. Previous BSI investigations from the Detroit Medical
Center have identified skin as the infection source in 15.9-35% of MRSA BSI (Kullar,
Davis, Levine, & Rybak, 2011; Kullar, Rybak, & Kaye, 2013; Murray et al., 2013).
Therefore, I was comfortable that there was enough ABSSSI-associated BSI to meet the
study sample size requirements. With respect to the study controls, although this was not
a matched case-controlled study, every effort was made to ensure that patients with
similar demographic and underlying comorbid conditions were collected for both
ABSSSI and ABSSSI with BSI. Lastly, I assumed that the data collected from the
Detroit Medical Center and Henry Ford Hospital electronic patient charts were accurately
reported and contained all of the information required to carry out the investigation and
there was no differences in the quality and completeness of the data between cases and
controls.
Limitations and Scope of the Study
The primary objective of this study was to evaluate and characterize the risk
factors for BSI in individuals with ABSSSI who reside in urban Detroit and have low
socioeconomic status. Data were collected on patients who were diagnosed and treated
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for ABSSSI at the Detroit Medical Center and Henry Ford Hospital. Limitations for this
case-control investigation included the retrospective study design, which can introduce
potential bias. Because of the potential for bias, case-control studies are not well suited
for detecting weak associations (odds ratio < 1.5). The retrospective design of casecontrol studies also make it more difficult to establish a clear temporal relationship
between the exposure and the outcome (Aschengrau, 2008). In addition, because of the
retrospective design of this study, the observations made during this investigation could
be constrained by the ability to capture accurate and complete information from the
database maintained by the Medical Center and Henry Ford Hospital. Another potential
limitation for this study was the fact that the patients in Detroit treated by the Detroit
Medical Center and Henry Ford Hospital may not be representative or generalizable to
the general population or to other urban centers throughout the United States. The
epidemiology of MRSA BSI may be dependent on the population (e.g., poor, uninsured,
etc.) that the Detroit Medical Center and Henry Ford Hospital serves (Tattevin et al.,
2012). It was also possible that patients may be treated differently (treatment bias)
depending upon their socioeconomic status (insured versus uninsured, education, income
levels) , which may impact the severity and overall outcome of the patients included in
this study (Lipsky, Kollef, et al., 2010). Specific organisms characteristics may have also
played a role as some strains of MRSA are more virulent (e.g., CAMRSA) or more drug
resistant then others, and these organisms maybe more common in the community
surrounding the Detroit Medical Center and Henry Ford Hospital compared to other
centers throughout the United States (Tattevin et al., 2012). The incorporation of
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inclusion and exclusion criteria and multivariable regression analysis in this investigation
should have helped control for some of the potential confounder variables that have been
encountered while conducting this study.
Significance of the Study
ABSSSI are one of the most common infections treated in both hospital and
community settings. These infections are not only common, but they are increasing in
prevalence (Amin et al., 2014; Pallin et al., 2008). Complications secondary to skin and
soft tissue infections can be severe and include infection of deep tissues and infections of
the bone (Moran et al., 2013). BSI represent one of the most severe complications
secondary to ABSSSI (Suaya et al., 2013). Although some limited information on BSI
secondary to ABSSSI exists, this study provided new insights on the risk of BSI in
patients with ABSSSI who reside in urban Detroit with low socioeconomic status. This
research contributed to positive social change by providing information on patient
characteristics and risk factors that can be used to improve the health outcomes of this
patient population.
Summary
ABSSSI are common infections that are increasing in prevalence and are
associated with the rapid increase in invasive CAMRSA (Moran et al., 2013; Pallin et al.,
2008). Although patients with ABSSSI are commonly treated in the community, patients
with severe ABSSSI often require hospitalization. These patients usually have a variety
of complications that can include deeper tissue abscesses and infection of the bone and
underlying comorbidities, such as diabetes and renal failure (Lipsky, Kollef, et al., 2010;
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Suaya et al., 2013). BSIs are associated with a high degree of morbidity and mortality
(van Hal et al., 2012; Yaw, Robinson, & Ho, 2014). While there are a limited number of
studies on BSI in patients with ABSSSI, scholars have not focused on a specific patient
population. This aim of this investigation was to evaluate the characteristics and risk
factors associated with ABSSSI-related BSI in patients residing in urban Detroit
Michigan. I also evaluated the impact of race/ethnicity on the severity of ABSSSIassociated BSI. The results of this investigation may increase the knowledge, prevention,
and treatment of ABSSSI-associated BSI in this patient population. In the next chapter, a
discussion of the literature regarding this gap in the collective knowledge base, along
with the theoretical frameworks, for this study, will be discussed.
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Chapter 2: Literature Review
Introduction
ABSSSIs are one of the most common infections encountered in both community
and health care settings (Pollack et al., 2015; Rajan, 2012). The overall prevalence of
ABSSSI is increasing. For example, the number of emergency department visits for skin
and soft tissue infections increased from 1.2 million to 3.4 million (a 3-fold increase, P
for trend < 0.001) from 1993 to 2005 (Pallin et al., 2008). ABSSSI are most commonly
treated on an outpatient basis; however, individuals with more severe infections require
hospitalization. ABSSSI can be associated with many complications. These include
deeper dermis infections requiring significant surgical interventions, infections of the
bone, gangrene, and amputation. One of the most severe complications of ABSSSI is
BSIs (Lipsky, Kollef, et al., 2010; Suaya et al., 2013). BSIs are associated with a high
degree of mortality (Lipsky, Kollef, et al., 2010; Suaya et al., 2013). Mortality secondary
to BSI has been linked to a number of risk factors, such as old age; immunosuppression;
comorbid underlying conditions such as diabetes, peripheral vascular disease, liver, and
kidney failure; and inadequate or inappropriate therapy (Bassetti et al., 2012; Itani et al.,
2011). Although there are a number of studies on the risk factors for mortality associated
with bloodstream infections, few scholars have evaluated evaluated skin and soft tissue
infection as a risk factor for BSI. Further, these researchers have not focused on ABSSSI
as a risk for BSI caused by the bacterial pathogen Staphylococcus aureus, and the risk of
BSI was not evaluated in an urban population with low socioeconomic status.
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In this chapter, the literature search strategy for this study, the theoretical
foundation, the literature review related to the key variables and concepts for the study,
and the overall summary and conclusions are reviewed.
Literature Search Strategy
The literature search strategy that was used for this review included multiple
databases, journals, and online resources. The review was central to identifying the
research gap, as well as previous investigations on skin and skin structure infections and
the secondary complication of BSI. Walden Library databases (PubMed, MEDLINE,
ProQuest Health & Medical Complete, Sage Premier, Google Scholar, and Web of
Science from 2008 – 2015) were explored using search terms such as ABSSSI, SSSI,
complicated skin and skin structure infections (cSSSI), CAMRSA, BSI, and risk factors
associated with SSSI BSI, socioeconomic status, health care access, race/ethnicity,
socioecological and ecological framework, chain of infection, and Web of Causation.
Additional resources that were explored included the CDC as well as the Medicare and
Medicaid websites for literature and information on risk factors, complications, treatment
guidelines, and medical insurance coverage policies with respect to ABSSSIs.
Articles relevant to the research topic were reviewed and selected for the literature
review if they met study inclusion criteria including the study date parameters, were not
redundant with previously selected papers, and supported the literature and research gaps.
Some select articles from prior to 2008 were included because of their pertinent
contribution to the study topic and their historical importance because CAMRSA is
associated with ABSSSI, and the prevalence of this organism was first reported during
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the later 1990s and early 2000-2005. The prevalence of this organism and its association
with ABSSSI continues to increase in the community.
Theoretical Foundation
The theoretical framework chosen for this study was selected after exploring
several theory constructs that were related to behavioral risk, patient risk factors or the
relationship of events, the causal agent, and the subsequent outcome of interest, which
was BSIs. The socioecological model was investigated as a possible framework for this
study because of the interrelationships between the individual and their community
(Burke, Joseph, Pasick, & Barker, 2009). Further, this model included a focus on the
importance of individual beliefs and behaviors in the context of the social environment
and its impact on health promotion(Glanz & Bishop, 2010). Ultimately, individuals are
responsible for their own health. However, the social determinants of health and the
social context in which they live contribute to the individual’s health (CDC, 2014b). This
fact is most apparent with minorities (e.g., African Americans, Hispanic
Americans/Latinos, Native Americans) whose health is more often disproportionately
affected compared to nonminority populations (European Americans) because of lower
levels of education, lower socioeconomic status, inadequate housing, and living in
proximity to unsafe environments (Thomas, 2014). While the socioecological model can
be used to establish the link between health behavior and social environmental influence,
it does not include an examination of patient characteristics that contribute to the risk of
disease. In addition, health behavior factors are typically collected prospectively via
surveys and are not documented in the electronic medical charts. This would make
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assessments of health behaviors difficult to analyze as contributors to individual risk of
BSI. Therefore, this model was not selected as the theoretical framework for this study.
Another potential theoretical framework that was evaluated was the chain of
infection. This theory includes a description of infection transmission as a chain of
events. Breaking any link of the chain could stop the transmission of infection
(Schneider, 2011). The components of the chain consist of the pathogen (virus,
bacterium, fungus, or parasite) causing disease, the reservoir or place in which the
microorganism resides and thrives and the portal of exit where the infecting organisms
leaves the reservoir and is then transmitted (mode of transmission) through the portal of
entry (mucous membrane, wound, etc.) to the susceptible individual (CDC, 2012).
Although the chain of infection theory is important to understanding the infectious
process, the focus of this theory is based primarily on breaking the chain of events
through prevention, epidemiologic surveillance, and interrupting transmission through
infection control practices. Infection risk as it relates to patient characteristics including
underlying disease states that contributes to infection acquisition, complications, and
patient outcomes is not accounted for with this theory; therefore, this framework was not
selected for this study.
The theoretical framework chosen for this study was the web of
causation(Krieger, 1994). Causation is explained by the relationship between events and
the connection between the causal agent and the affected entity. It links a preceding
event with a subsequent outcome, emphasizes the mechanism of action, and provides a
process that leads to the event of interest (Aschengrau, 2008). The cause can be defined
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as a condition that plays a role in the development of disease. The occurrence of a
disease within a population can be related to genetic abnormalities, microorganisms,
social structural and behavioral differences, environmental factors, and other associated
characteristics (Norton, 2015). The web of causation applied to my research because it
was not clearly known why patients with ABSSSI went on to develop the complication of
BSI. The underlying assumption was that there was a causal pathway that differs from
patients with ABSSSI versus those with ABSSSI with BSI. Some of these characteristics
may have been related to race/ethnicity and access to health care. In this investigation, I
determined the underlying characteristics in patients with ABSSSI that were associated
with BSI in urban Detroit.
Skin and Soft Tissue Infections
ABSSSIs are one of the most common infections treated in the community and
the hospital environment (Edelsberg et al., 2009; Pallin et al., 2008). The National
Hospital Ambulatory Medical Care Survey (NHAMCS, 2011) indicated that diseases of
the skin and subcutaneous tissue accounted for 3.9% of emergency department visits.
Further, skin and soft tissue infections were one of the top 20 leading diagnosis
accounting for 2.4% of all emergency department visits in 2011(CDC, 2011).
Additionally, in data collected from U.S. emergency departments between the years 1997
and 2005, researchers indicated that the prevalence of ABSSSI has increased by as much
as 50% and involving up to 14.2 million patients in 2005 (Hersh, Chambers, Maselli, &
Gonzales, 2008; Pallin et al., 2008).
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ABSSSIs result from an invasion of the epidermis, dermis, and subcutaneous
tissues by microbial pathogens resulting in an inflammatory response leading to
erythema, pain, swelling, and often a purulent discharge (Dryden, 2010). The skin is
colonized with a variety of microbial flora that can act as an inhibitory barrier to
pathogenic invading organisms. When this barrier is compromised via a break in the
skin, ulcers, burns, traumatic or surgical wounds, or pathogenic organisms can gain
access and cause infection (Dryden, 2009; Ray et al., 2013a). SSSIs can be classified as
uncomplicated and complicated, which are terms that can be useful for describing the
severity of these infections. However, SSSI descriptions are more useful to for
understanding the pathogenesis and designing treatment strategies. In fact, the term
ABSSSI was adopted by the Anti-Infective Drugs Advisory Committee in 2010 in an
attempt to focus on bacterial infections for new antibiotic clinical trials, as well as to
reduce the ambiguity associated with the term cSSSI that includes bacterial and
nonbacterial causes, bite wounds, bone and joint infections, diabetic foot infections, and
catheter-associated infections. Diagnoses under the term ABSSSI included cellulitis,
erysipelas, major cutaneous abscess, and burn infections (Rajan, 2012). Cellulitis is an
infection of the deep dermis and subcutaneous tissue. It is characterized by
inflammation, induration, redness, and poorly demarcated borders. Erysipelas is a form
of cellulitis affecting the superficial dermal lymphatic glands, and it differs from cellulitis
by having raised borders that are sharply demarcated. Cutaneous abscesses are defined as
a purulent collection of pus within the dermis of the skin that are often accompanied by
inflammation, redness, induration, swollen lymph nodes, and fever. Overall, cellulitis
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and cutaneous abscess appear to be the most common ABSSSIs encountered in
community and hospital settings. In a study evaluating the epidemiology and outcomes
of 1,096 patients with cSSSI in hospitalized patients, cellulitis was the most common
accounting for 56.8% of all infections followed by cutaneous abscess (35.1%), skin
ulcers (10.3%), surgical wounds (8.9%), and diabetic skin wounds at 6.6% (Zervos et al.,
2012). This finding was further corroborated by Itani et al. (2011) who evaluated 43,201
patients hospitalized with cSSSI. Of those patients with Gram-positive bacterial cSSSI,
49.4% were diagnosed as cellulitis, abscess, or cellulitis with abscess (Itani et al., 2011).
Further, in an evaluation of a large database from the Kaiser Permanente Medical Care
Program between the years 2006 to 2009, Ray et al. (2013b) identified 648,699 patients
with SSSI. Of these, 63% (405,798) were diagnosed as cellulitis and abscess (Ray et al.,
2013b).
Pathogens Responsible for Acute Bacterial Skin and Skin Structure Infections
Although a variety of organisms are capable of causing ABSSSI, Gram-positive
bacteria such as Staphylococcus aureus and Streptococci species are the most common
bacterial pathogens. Under certain circumstances, Gram-negative and anaerobic bacteria
may be involved, especially in polymicrobial skin and skin structure infections such as
diabetic foot infections and chronic skin ulcers (Dryden, 2010; Moran et al., 2013).
Streptococcus species such as Streptococcus pyogenes are the primary cause of cellulitis
and erysipelas, whereas Staphylococcus aureus are most commonly involved in
cutaneous skin abscesses. To evaluate the most common organisms involved in cSSSI,
Sader et al. (2007) collected 4,674 nonduplicate bacterial isolates from 38 medical
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centers in the United States over the years 2000-2005 from patients with documented
cSSSI. Of these isolates, 48.1% (2,248) were identified as Staphylococcus aureus (S.
aureus), and 4.2% were beta-hemolytic streptococci (Sader et al., 2007). The remaining
bacterial pathogens primarily consisted of Pseudomonas aeruginosa, E. coli, and
Enterococcal species (Sader et al., 2007). Of the S. aureus, 43.5% were resistant to the
semisynthetic penicillin antibiotic methicillin, commonly referred to as MRSA, and
56.5% were MSSA (Sader et al., 2007). Infection due to MRSA is problematic because
penicillins and cephalosporins (known collectively as beta-lactams antibiotics) are not
effective leaving clinicians with fewer and often more toxic therapeutic choices to treat
these infections (Rehm & Tice, 2010). In addition, patients infected with MRSA
generally have more complicated treatment outcomes including longer hospital stays,
increased failure rates, higher mortality rates for invasive infections, and increased health
care costs (Klevens et al., 2007; Ray et al., 2013b). The overall prevalence of MRSA
infections is increasing. In data from a national surveillance network composed of 300
clinical microbiology laboratories across the United States, Styers, Sheehan, Hogan, and
Sahm (2006) revealed that MRSA infection rates have increased during the years 1998 to
2005. In data collected from a large U.S. health plan database, Ray et al. (2013b)
reported that MRSA-associated SSSIs increased from 5% in 1998 to 42% in 2005 and
37% in 2009.
Community-Associated, Methicillin-Resistant Staphylococcus Aureus
The CDC (2014a) reported a total of 75,309 invasive MRSA infection cases for
2012 with an incidence rate of 24 cases (CI 20.64-28.10) per 100,000 population. This
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increase in invasive MRSA infections can be contributed to the epidemic rise of
CAMRSA (Pollack et al., 2015). Risk factors for hospital-associated MRSA (HAMRSA)
have been well documented and include hospitalization, recent surgical procedures,
antibiotic exposure, residence in long-term care facilities, catheters, and medical devices
including patients with renal dysfunction/hemodialysis and diabetic patients (Pulia,
Calderone, Meister, Santistevan, & May, 2014; Rehm & Tice, 2010). Individuals with
CAMRSA infections, however, are not associated with these traditional risk factors
(Rehm & Tice, 2010). Individuals with CAMRSA infections can present with a
relatively healthy background, such as athletes via sports exposure, individuals associated
with overcrowded living conditions, poor hygiene, homeless, children in day care,
incarceration, intravenous drug users, men who have sex with men, individuals with
advanced age, youth (including newborns), recent contact with an individual with a
similar skin infection, recent antibiotic exposure in the community, skin abrasions, open
wounds, lesions attributed to spider bites, diabetes, and peripheral vascular disease
(Meddles-Torres, Hu, & Jurgens, 2013; Pulia et al., 2014). Prior to 2000, MRSA was
considered a rare pathogen associated with community-acquired infections (Moran et al.,
2013). However, the prevalence of MRSA acquired from the community increased after
the year 2000. In a single center study in a Los Angeles emergency department, Moran,
Amii, Abrahamian, and Talan (2005) revealed that between the years 2000 and 2005, the
prevalence of MRSA infections derived in the community more than doubled from 29%
to 64%. CAMRSA has now been described as the leading cause of SSSI in the United
States (Hersh et al., 2008; Raygada & Levine, 2009). In a follow-up study with 422
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patients evaluated for skin and soft tissue infections from 22 geographically diverse
emergency departments across the United States, Moran et al. (2006) determined that
CAMRSA accounted for 59% of SSSI. In the US Healthcare Cost and Utilization Project
National Inpatient Sample from 2000-2004, researchers determined that total hospital
admissions increased by as much as 29% (Edelsberg et al., 2009). The largest increase in
CAMRSA infections was among younger patients (< 65 years of age) and for urban
rather than rural patients (Edelsberg et al., 2009). During this time period, hospital
admissions were greatest for patients with more superficial infections, such as cellulitis
and cutaneous abscess, as opposed to health care-associated deeper infections (Edelsberg
et al., 2009). CAMRSA-associated SSSI continues to increase in prevalence. Using
ICD-9 codes from the National Ambulatory Medical Care Survey and the National
Hospital Ambulatory Medical Care Survey, researchers determined that the incidence of
SSSI increased 84.7% over the years 1997-2002 and 2003-2008 (Meddles-Torres et al.,
2013). During this time period, the primary infection type was cutaneous abscess, which
increased by 98.3% over a 5-year period (Meddles-Torres et al., 2013). The increase in
CAMRSA infections over the last decade is considered a public health threat (CDC,
2014a; Edelsberg et al., 2009).
Compared to HAMRSA, CAMRSA are more virulent carrying a wide range of
exotoxins that cause tissue necrosis leading to severe disease (Rehm & Tice, 2010).
Genetically, CAMRSA carries a smaller gene type known as staphylococcal cassette
chromosome mec (SCCmec) Type IV & V. This gene cassette is associated with the
methicillin-resistant phenotype that defines MRSA, but is different from HAMRSA

29
strains carrying the much larger multidrug resistant SCCmec cassette Types I-III (Chua,
Laurent, Coombs, Grayson, & Howden, 2011). The most common circulating CAMRSA
types in the United States over the last 10 years are USA300 and USA400 (Klevens et al.,
2007; Maree et al., 2007; Moran et al., 2013). These strains are defined on the basis of
their pulse-field gel electrophoresis DNA fingerprint (Chua et al., 2011). CAMRSA
strains were first identified and documented in children in the mid-1990s with USA400
being the predominant strain. Since that time, USA300 has become the epidemic clone
strain that common in the United States and is the most common bacterial pathogen
causing ABSSSI (Chua et al., 2011; David & Daum, 2010; Rehm & Tice, 2010).
The CDC (2010) defined CAMRSA infections as MRSA infections that occur in
the outpatient settings where the culture of MRSA has been obtained within 48 hours of
the hospital admission. In addition, patients who meet the definition of CAMRSA
infection do not have a history of MRSA infection or colonization and have no history of
hospitalization, admission to a nursing home, hemodialysis, or surgery within the past
year. These patients also do not have permanent indwelling catheters or medical devices
that are in contact with the skin (CDC, 2010). While not a part of the CAMRSA
definition from the CDC, others have defined CAMRSA on the basis of antibiotic
susceptibility because, in general, CAMRSAs are susceptible to all antibiotics except
beta-lactams and are, therefore, methicillin-resistant. In addition, some researchers
include the genotype as a part of the definition with CAMRSA containing the novel
smaller SCCmec IV or V cassette and the lukSF-PV genes, which encodes for the
Panton-Valentine leukocidin (PVL) toxin. The PVL toxin is a white blood cell exotoxin
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and is responsible for some of the most severe CAMRSA infection presentations (Herold
et al., 1998; Vandenesch et al., 2003).
Investigations Evaluating Acute Bacterial Skin and Skin Structure Infections
Since the epidemic of CAMRSA first erupted, a number of studies have been
conducted to examine the prevalence, risk factors, and health outcomes of patients with
ABSSSI. Moran et al. (2006) conducted a prospective prevalence study of adult patients
with SSTIs who were treated in the emergency departments of the Emergency ID Net,
which is a network of university-affiliated hospitals from 11 cities across the United
States. Individuals who had a purulent SSTI that was less than less than 1 week in
duration were eligible for enrollment into the study (Moran et al., 2006). A total of 422
patients were enrolled into the study (Moran et al., 2006). Overall, the patients tended to
be younger in age (median age of 39), more commonly men (62%), and mostly nonHispanic blacks (49%; Moran et al., 2006). Abscess was the most common type of
infection accounting for 81% of the patients followed by wound at 11% and cellulitis
with purulent exudate at 8% (Moran et al., 2006). Staphylococcus aureus was the most
common pathogen associated with SSTI with MRSA accounting for 59% of patients
(prevalence range 15-74%; Moran et al., 2006). The other predominant organisms
identified were methicillin-susceptible Staphylococcus aureus accounting for 17% and
streptococcus species (7%; Moran et al., 2006). Of the 218 MRSA isolates recovered,
99% were determined to be CAMRSA on the basis of the CDC pulse-field
electrophoresis definitions (Moran et al., 2006). Infections with MRSA included recent
antibiotic use, abscess associated with a spider bite, history of MRSA infections, or close
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contact with an individual who had a similar SSTI (Moran et al., 2006). Presence of
underlying comorbid conditions and race and ethnicity were not associated with MRSA
skin infections (Moran et al., 2006). However, when these factors were applied to a
multivariable logistic regression analysis, Black race and the presence of a skin abscess
were independently associated with MRSA skin and skin structure infections (Moran et
al., 2006). MRSA was the most common organism that was identified with ABSSSI
across 11 diverse U.S. cities (Moran et al., 2006).
Maree et al. (2007) conducted a study on CAMRSA infections from 1999 to 2004
in Los Angeles at the Harbor-UCLA Medical Center. This hospital system is a tertiarycare urban, hospital in Los Angeles County. CAMRSA strains were defined as MRSA
strains isolated < 72 hours of hospitalization (Maree et al., 2007). During this time
period, a total of 352 patients with MRSA cultures were identified. Of these, 229 (65%)
were men with a median age of 50 years. Of these patients infecting organisms, 128 were
identified as CAMRSA via SCCmec type IV phenotype (Maree et al., 2007). When
compared to HAMRSA, patients tended to be younger (48 vs. 54 years; p =0.02) and
were more likely to have MRSA cultured from wounds, a shorter length of hospital stay
prior to MRSA culture, and an infection identified after the year 2003 (Maree et al.,
2007). CAMRSA infections were becoming more commonly encountered, were more
likely to cause skin and skin structure infections, and tended to be more aggressive
causing an infection with a higher severity and associated with a longer hospital stay
(Maree et al., 2007).
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In a large retrospective study of skin and soft tissue infections, Ray et al. (2013a)
evaluated the incidence, offending pathogens, and patient characteristics. Over the years
2009 to 2011, a total of 376,262 SSTIs were examined. Of the patients who provided
cultures (58,794), Staphylococcus aureus was the most common pathogen isolated (81%)
with 46% of these identified as MRSA (Ray et al., 2013a). The incidence of SSTI was
496 per 10,000 person-years and was highest in individuals >65, Native Americans,
African Americans, individuals identified as multiracial, and individuals with diabetes
(Ray et al., 2013a). Asian Americans and Hispanic Americans had a reduced rate of
SSTIs while African Americans between 18 and 50 years of age were at a
disproportionately high risk for SSTI compared to European Americans (Ray et al.,
2013a). In addition, Hispanic American and African American patients were more likely
to have MRSA identified as the causative pathogen for SSTI compared to European
Americans (OR: 1.79; CI; 1.67-1.92, OR: 1.24, CI; 1.18-1.31), and Asian American
patients were less likely to have MRSA (OR: 0.73, CI; 0.68-0.78). Further, individuals of
lower income status were at an increased risk of MRSA SSSTI (Ray et al., 2013a).
Patients with diabetes were found to have approximately twice the rate of SSTI (RR:
1.93, CI: 1.90 to 1.96) compared those without diabetes (Ray et al., 2013a). In a posthoc
analysis evaluating race and ethnicity by age group, Asian Americans and Hispanic
Americans were found to have lower rates of SSTI at every age group except for children
less than 5 years of age (Ray et al., 2013a). When evaluating the age bracket of 18 to <
65, African Americans had SSTI rates substantially higher (RR: 1.27, CI; 1.23 to 1.31
compared to European Americans of the same age (Ray et al., 2013a). However, at all
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other age brackets, African Americans had SSTI rates similar or lower than European
Americans (Ray et al., 2013a). Overall, after adjusting for demographic characteristics,
the investigators concluded that the risk of SSTI was greatest for individuals with
diabetes, those of lower socioeconomic status, and children under 5 years of age while
Asian Americans were of lower risk. In addition the rate of SSTI varied by both age and
race/ethnicity and warranted further investigation (Ray et al., 2013a).
Skin- and Soft Tissue-Associated Complications
Complications from SSTIs can be severe and include necrotizing infections
requiring extensive surgery, gangrene, amputation, bone and joint infections (including
osteomyelitis), bloodstream infections, and sepsis (Dryden, 2010; Lipsky, Tabak, et al.,
2010; Sreeramoju et al., 2011; Wilson et al., 2011). Using a large repository U.S. health
care database, Suaya et al, 2013 evaluated 2,227,401 SSTI episodes and their
complications diagnosed from 2005 to 2010. The most common SSTI type was abscess
and cellulitis accounting for 50.5% and 54.4%, respectively, and 10% of these patients
were diabetics (Suaya et al., 2013). Compared to diabetic patients, nondiabetic patients
with SSTIs were more likely to be diagnosed in ambulatory settings (96.2 vs. 88.7%;
p<0.01; Suaya et al., 2013). Complications secondary to SSTI were noted to occur more
than five times higher in patients who had diabetes compared to nondiabetic patients
(4.9% vs. 0.8%; p<0.01; Suaya et al., 2013). Osteomyelitis was the most common
complication in patients with SSTIs diagnosed in ambulatory settings and was more
commonly observed in patients with diabetes compared to nondiabetic patients (3.3 vs.
0.4%; p< 0.01; Suaya et al., 2013). Overall, complications were highest and more severe
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among the hospitalized patients. In these patients, bloodstream infections, endocarditis,
and sepsis were the most common complications occurring in 24.7 and 16.3% of patients
with and without diabetes, respectfully (Suaya et al., 2013). The rate of subsequent
rehospitalizations was nearly double for patients with diabetes compared to nondiabetics
(15.1% compared to 7.8%, respectfully; Suaya et al., 2013). Overall, patients with
diabetes had both higher rates of SSTI complications and subsequent hospitalizations
(Suaya et al., 2013).
Lipsky et al. (2010) also evaluated complications in diabetic patients with SSTI.
A total of 3,030 hospitalized patients with positive bacterial cultures from 97 U.S.
hospitals over the years 2003 and 2007 were evaluated. Factors that were significantly
associated with mortality included the severity of illness upon hospital admission (p<
0.001), the type of SSTI (cellulitis vs. ulcer vs. surgical infection; p<0.001) and a nonfoot
SSTI location (p< 0.05; Lipsky et al., 2010). Patients with skin and soft tissue wound
infections that had polymicrobial isolates including Pseudomonas aeruginosa or nonPseudomonas gram-negative monomicrobial bacteria had a significantly increased
mortality rate (p< 0.01 and p< 0.001, respectfully; Lipsky et al., 2010). Severity of
illness, transfer from another acute care hospital, patients from nursing homes, or
individuals with wound cultures who demonstrated gram-negative pathogens including
Pseudomonas aeruginosa and polymicrobial infections including MRSA were associated
with increased length of stay and hospital costs (Lipsky et al., 2010). Further, patients
with SSTI wounds infected with MRSA tended to be more severely ill on clinical
presentation (Lipsky et al., 2010). Overall, Lipsky et al. identified significant
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independent risk factors for prolonged hospital stays: increased costs and mortality. In
addition, patients with SSTI who had wounds with MRSA tended to have greater severity
of illness at clinical presentation (Lipsky et al., 2010). Scholars identified MRSA,
diabetes, polymicrobial infections that included gram-negative pathogens, and severity of
illness on hospital presentation as risk factors for SSTI complications.
Infections Secondary to Acute Bacterial Skin and Skin Structure Infections
In the United States, BSI ranked as the 11th leading cause of death in 2008
(Minino, Murphy, Xu, & Kochanek, 2011). Staphylococcus aureus is one of the most
common pathogens causing BSI in both community and health care settings (Sievert et al.,
2013). Staphylococcus aureus BSIs are associated with a high degree of complications
including metastatic spread causing septic arthritis, vertebral osteomyelitis, and infective
endocarditis (Corey, 2009; del Rio et al., 2009). Mortality secondary to Staphylococcus
aureus is significant and ranges from 20-40% (Gould, 2007; Kobayashi, Yokota,
Takahashi, Arioka, & Fukui, 2014). There are a variety of risk factors that have been
associated with the increased risk of mortality secondary to Staphylococcus aureus BSI.
While conducting a systematic review of predictors of mortality secondary to
Staphylococcus aureus BSI, van Hal et al. (2012) identified age (1.3 fold increase for
every decade of life), ethnic origin (27.7/100,000 for European Americans compared to
66.5/100,000 population for African Americans), and underlying comorbid conditions
(presence of alcoholism, immunosuppression, cirrhosis, congestive heart failure, cancer,
chronic renal failure requiring dialysis, as well as the presence of multiple comorbid
conditions as important factors that predicted mortality). In addition, the source of
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infection, and whether Staphylococcus aureus BSI developed in the community versus in
hospital settings, was also a factor. Of interest, MRSA BSI had a much higher rate of
mortality compared to MSSA (van Hal et al., 2012).
The relationship between MRSA BSI and increased mortality was previously
documented by Shurland et al. (2007) who evaluated 438 patients with MRSA infections
at a Veterans Affairs medical center. Patients with MRSA BSI had a higher mortality risk
compared to patients with MSSA BSI (RR, 1.7, 95% CI: 1.3-2.4, p< 0.01; Shurland et al.,
2007). In addition, patients who died from MRSA infections tended to be older, have
more underlying diseases, and were more likely to have severe sepsis compared those
patients who survived (Shurland et al., 2007). SSTIs were listed as one of the most
common sources of BSI with 29.3% listing MRSA as the causative pathogen versus
22.5% MSSA (Shurland et al., 2007).
Contributing to data impacting the outcome of patients with MRSA BSI, Yaw
(2014), using an observational cohort study design, examined the long-term outcomes of
patients with MRSA and MSSA bacteremia. Patients with Staphylococcus aureus BSI
from July of 1997 to June of 2007 were evaluated for crude survival time. Although
infection-related mortality was not statistically different between MRSA and MSSA BSI
after adjusting for known predictors, such as comorbid conditions, severity of illness,
cancer, and association with long-term care facilities, patients with MRSA BSI had much
shorter survival time (14 months, [IQR 1-86] compared to MSSA BSI at 54 months [IQR
3-105]; hazard ratio 1.46, 95% CI; 1.8-79; p = 0.01; Yaw, 2014). Yaw et al. concluded
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that the findings of worsening long-term outcomes had treatment implications for MRSA
BSI.
ABSSSI is a common source of Staphylococcus aureus BSI (Lipsky, Kollef, et
al., 2010). In data from the meta-analysis of predictors of mortality in Staphylococcus
aureus BSI from 41 investigations, Van Hal et al. (2012) indicated that patients with BSI
secondary to ABSSSI were at an intermediate to moderate risk (2-9 fold increased risk) of
mortality compared to patients with urinary tract, intravenous catheters, ear, nose, and
gynecological foci listed as the source of infection. Since the epidemic spread of
CAMRSA starting in 2000, strain type USA 300 has become the predominant cause of
ABSSSI in the United States (Zervos et al., 2012). The aggressive spread of this organism
is of importance because CAMRSA is considered a highly invasive pathogen capable of
infecting individuals without the traditional risk factors for MRSA infections. As part of a
surveillance study evaluating the molecular characteristics and clinical characteristics of
patients infected with Staphylococcus aureus strains from 2000 to 2008, Tattevin et al.
(2012) identified that the USA 300 strain type accounted for 55% (304/549) of BSIs and
that this strain type was the predominant MRSA clone causing community-associated
infections. In addition, there was a strong correlation (Pearson r = 0.953) between USA
300 ABSSSI and USA 300 BSI, indicating that USA 300 (CAMRSA) ABSSSI was a
primary source of BSI and that efforts to control USA 300 ABSSSI may decease
subsequent BSIs and their patient outcome consequences (Tattevin et al., 2012). Further,
Tattevin et al. claimed that USA 300 BSI was now predominantly a community infection
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and had emerged as a consequence of USA 300 ABSSSI in the poor urban area of San
Francisco.
In the only study to determine risk factors among patients with BSI hospitalized
for SSTI, Lipsky, Kollef, et al. (2010) evaluated a large database of adult hospitalized
patients from 97 hospitals in the United States from the years 2003 to 2007. Of the 8,747
patients evaluated, 1,021 (11.7%) were determined to have BSI (Lipsky, Kollef, et al.,
2010). Independent predictors of BSI were old age, male sex, comorbidities such as
coronary heart disease, presence of infected devices of prosthesis, health care-associated
infections, abnormal vital signs such as respiratory rate, low or high pulse rate,
0

temperature less than 35.6 C, and abnormal white blood cell counts (p< 0.001; Lipsky,
Kollef, et al., 2010). Lipsky, Kollef, et al. identified that risk factors for BSI were
important for early recognition and to manage complications including morbidity and
mortality associated with BSI. The limitations of this study were that (a) Lipsky, Kollef,
et al. only concentrated on hospitalized patients and, therefore, the findings are not
generalizable to patients with community infections and (b) patients selected were not
specific to an urban city setting where access to health and other socioeconomic factors
could have an influence on the risk factors associated with BSI secondary to ABSSSI
(Lipsky, Kollef, et al., 2010).
Socioeconomic Factors Contributing to Infection
Socioeconomic factors affect individual health outcomes. The socioeconomic
environment of the neighborhood can have both direct and indirect impact on health.
Direct effects on health include injuries from crime, environmental hazards, and illness
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from toxic exposures (Khabbaz et al., 2014; Lantz & Pritchard, 2010). Indirect
influences on health include chronic exposure to social stressors such as poverty,
unemployment, and discrimination. Additional mechanisms that link the socioeconomic
environment to health include health risk behaviors such as poor diet, physical inactivity,
and tobacco use and the lack of adequate housing and access to health care services
(Lantz & Pritchard, 2010). Certain patient populations may be at higher risk for
infectious disease complications and worse treatment outcomes (Holman et al., 2011;
Khabbaz et al., 2014; Moore et al., 2012). Using data from the National Health and
Nutrition Examination Survey (NHANES) from 1988 through 1994, Zajacova et al.
(2009) evaluated socioeconomic status and its relationship to chronic and persistent
infections including Helicobacter pylori infections, periodontal infections, herpes viruses,
and hepatitis viruses in 19,275 individuals. Demographic variables included
race/ethnicity, education, and income variables (Zajacova et al., 2009). Across all age
and race/ethnic groups, the burden of infection was highest among those with the lowest
education and income (Zajacova et al., 2009). Independent of education and income,
non-Hispanic Black adults and Mexican Americans had a significantly higher burden of
infection compared to non-Hispanic White adults (Zajacova et al., 2009). In addition,
investigators evaluating race/ethnicity and low socioeconomic status have reported higher
hospital readmission rates and increased risk of infection complications including sepsis
severity highest among African Americans (Acosta et al., 2013; Morris et al., 2014). The
rates of invasive CAMRSA infections are highest among Blacks compared to Whites and
in individuals with lower socioeconomic status in the United States (Klevens et al.,
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2007). In a study on trends in U.S. hospital admissions for SSTI between 1998 and 2004,
the highest rates for SSTI admissions were among individuals younger than 65 years of
age and for urban rather than rural hospitals (32% vs. 11%; Khabbaz et al., 2014; Lantz
& Pritchard, 2010; Moore et al., 2012). The higher rates of SSTI among urban hospitals
is of interest because inner city patient populations are more likely to be diverse, have
higher rates of poverty, health risk behaviors, and poor access to health care resources
(Khabbaz et al., 2014; Lantz & Pritchard, 2010; Moore et al., 2012). In order to make
improvements in individual health outcomes, it is important to evaluate patients in urban
settings who have low socioeconomic status and are at high risk for infections and
complications.
Summary
The pertinent literature regarding ABSSSI, the pathogens responsible for causing
this infection, and the relationship between ABSSSI and bloodstream infection was
reviewed in this chapter. The theoretical framework for this study, web of causation, was
used to describe the relationship between events and the causal agents producing the
outcome of intent and identifying the risk factors associated with BSI. It was not clearly
known why patients with ABSSSI develop BSI. However, individuals with ABSSSI who
reside in urban environmental settings are at higher risk for complications secondary to
ABSSSI including BSI because of socioeconomic status, race/ethnicity, high risk health
behaviors, and poor access to health care resources. Methicillin-resistant Staphylococcus
aureus is the primary pathogen involved in ABSSSI including patients with secondary
BSI. CAMRSA is a highly virulent organism and the most common bacterial pathogen
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causing infections including ABSSSI in the community. There have been a number of
investigations on ABSSSI in recent years. These researchers have identified risk factors
for ABSSSI including race, such as African Americans; age (< 65 years); and a number
of comorbid conditions, such as diabetes. However, there is little to no information
regarding patients with ABSSSI and their risk for BSI, and there are no studies on inner
city adults of low socioeconomic status. In this chapter, I documented the knowledge gap
regarding ABSSSI and the risk of BSI, which supported the need to evaluate these risk
factors.
In the next chapter, the methods section for the investigation will be described.
This section includes the research questions that were addressed, the rationale for the
research design, ethical considerations, patient population, justification for the selected
sample size, patient characteristics to be collected, and statistical approaches that were
used to analyze the data.
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Chapter 3: Research Method
Introduction
The purpose of this study was to evaluate the health outcomes of patients with
low socioeconomic status in an urban city environment who had ABSSSI-related S.
aureus BSI infection. The primary aim of this investigation was to characterize and
determine the risk factors for patients with ABSSSI with concomitant BSI compared to
patients with ABSSSI alone admitted to the Detroit Medical Center (DMC) and Henry
Ford Hospital (HFH). The secondary aim was to determine whether race/ethnicity
impacted the severity of ABSSSI-associated BSI.
A detailed description of the methodology that was used to carry out this
investigation will be described in this chapter. In the first section of the chapter, I
describe the research design and rationale. Included in this section is a description of the
dependent and independent variables, the research design, and the research questions and
their importance for advancing the knowledge about the subject area. Within this
chapter, the target population is defined, and the estimated sample size, power and
desired effect size, sampling procedures, time frame, and the inclusion and exclusion
criteria are presented. The procedures that were used for gaining access to the data, data
collection, and a description of the study participants’ demographics and characteristics
are also included. In addition, the research variables are defined and a description of how
the variable was measured is provided. Procedures for data cleaning, as well as the
software for statistical analysis that was used, are described. The planned statistical
analysis, rationale for variable inclusion, and procedures for data interpretation are
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discussed. Threats to internal and external validity and ethical concerns are also
discussed. Lastly, this chapter will provide a summary of the design and methodology, as
well as a transition statement for Chapter 4.
Research Design and Rationale
An observational, case-control study design was chosen to evaluate BSI
associated with ABSSSI. This quantitative research design was selected because it is a
preferred method for examining the type of research questions and hypotheses testing that
was performed in this investigation, as detailed below (Aschengrau, 2008; Creswell,
2009; Song & Chung, 2010). The primary objective of this investigation was to evaluate
the risk factors associated with BSI in patients residing in urban Detroit Michigan. A
secondary purpose of this investigation was to explore the impact of socioeconomic
status on the severity of BSI. Risk factors for BSI in patients who had been hospitalized
for ABSSSI have been previously evaluated (Lipsky, Kollef, et al., 2010). However, risk
factors in patient populations with low socioeconomic settings have not been identified.
A case-control study design was selected because it is one of the most efficient methods
to evaluate exposure and disease. Case-control studies start with the subjects who have
outcome of interest at the outset of the investigation, and then the investigator looks back
in time to examine potential causative factors. After the outcome has been identified,
subjects with the outcome or disease are categorized as cases, and subjects without the
outcome/disease are categorized as controls. By comparing subject characteristics
including exposure factors between cases and controls, the potential cause and risk
factors for disease development can be derived. Compared to cohort studies, case-control
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studies are better suited for evaluating rare events, are more rapid and less expensive to
complete, require fewer subjects, and accommodate the assessment of multiple risk
factors for a single outcome (Song & Chung, 2010). This study design was considered a
basic and valid epidemiologic approach to measure the relationship between an exposure
and disease development(Aschengrau, 2008). Case-control studies have been routinely
used to examine risk factors associated with ABSSSI, MRSA, and MRSA BSI (Bassetti
et al., 2012; Davis et al., 2007; Shurland et al., 2007). The higher frequency of ABSSSI
compared to other infections, retrospective design, and the availability of electronic
medical case documentations limited any resource and time constraints for collecting and
analyzing data. The primary dependent (outcome) variable for this investigation was the
diagnosis of BSI. The independent variables were patient characteristics and factors that
may determine whether patients with ABSSSI develop secondary BSI; they included age,
gender, educational level, income, race/ethnicity, diabetes, cardiovascular disease, renal
failure, cirrhosis, intravenous drug use, recent hospitalization, recent MRSA infection,
alteration in body temperature, WBC, and receipt of antibiotics in the past 30 days
(Lipsky, Kollef, et al., 2010; Tattevin et al., 2012).
The secondary purpose of this investigation was to evaluate the impact of social
economic status and the degree of severity associated with ABSSSI-associated BSI.
Social determinants of health and the social context in which individuals live are
contributing factors to an individual’s health (CDC, 2014b). The relationship between
social determinants and its impact on health has been demonstrated most often in
minorities such as African Americans, Hispanic Americans/Latinos, and Native
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Americans. Individuals with lower socioeconomic status and minimal education levels
who are living in inadequate housing all have been shown to contribute the individual
health status (Thomas, 2014). To determine the impact of socioeconomic status on
severity of disease, race/ethnicity, age, education level income, and insurance status was
used as independent variables. Research questions and the variables that were evaluated
in this investigation are listed in Table 1 and 2.
Summary of Variables by Research Question
1.

Are there significant differences in clinical characteristics, risk factors,
and socioeconomic factors between patients with ABSSSI and ABSSSIassociated BSI?
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Table 1
Variables
Variable

Independent/De
pendent

Variable Type

Statistical Test

Race/Ethnicity

Independent

Categorical; African-American will serve as
the reference variable, Caucasian, Hispanic
and Other will serve as the other variables

Chi-Square/Logistic
Regression

Gender

Independent

Dichotomous; Male/Female

Chi-Square/Logistic
Regression

Age

Independent

Categorical, 18-35, 36-50, 51-75, > 75

Chi-Square/Logistic
Regression

Education

Independent

Categorical, hierarchy variables: < high
school, H.S. graduate, college graduate,
graduate school

Chi-Square/Logistic
Regression

Income

Independent

Categorical; hierarchy variable as poverty <
$24,250, $24,250-$32,500, low income,
$32,501-$49,999, middle income $50,000$100,000 or upper middle income > $100,000$200,000 per household of 4

Chi-Square/Logistic
Regression

Insurance Status

Independent

Dichotomous variable, present or absent

Chi-Square/Logistic
Regression

Renal Failure,
Diabetes,
Cardiovascular
Disease, hepatic
disease, IVDU,
paraplegia,
HIV/AIDS,
immunosuppres
sion (steroids,
radiation,
chemotherapy)

Independent

Dichotomous variable, present or absent

Chi-Square/Logistic
Regression

Temperature,
White Blood
Cell Count
(WBC)
Recent
Hospitalization
within the last
180 days

Independent

Categorical; < 35.60C or > 38.00C, WBC > 11
x 109 cells/L

Chi-Square/logistic
Regression

Independent

Dichotomous; present or absent

Chi-Square/Logistic
Regression

Recent
Hospitalization
for MRSA or
MSSA infection
within the last
60 days

Independent

Dichotomous; present or absent

Chi-Square/Logistic
Regression

Receipt of
antibiotic within
the last 30 days

Independent

Dichotomous; present or absent

Chi-Square/Logistic
Regression

ABSSSIassociated BSI

Dependent

Dichotomous; present or absent

Chi-Square/Logistic
Regression
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2.

Is race/ethnicity associated with disease severity (based upon surgical
interventions [e.g., incision and drainage, wound debridement,
amputation]), admission to the ICU, or shock between patients with
ABSSSI and ABSSSI-associated BSI?

Table 2
Variables and Tests
Variable

Independent/Dependent Variable Type

Statistical Test

Race/ethnicity

Independent

ChiSquare/Logistic
Regression

Surgical
intervention,
incision and
drainage in
OR, wound
debridement
and
amputation,
admission to
ICU or shock

Dependent

Categorical;
AfricanAmerican, will
serve as the
reference
variable and
Caucasian,
Hispanic and
other will be the
other variables
Dichotomous;
Incision and
drainage
present/absent,
wound
debridement
present/absent,
amputation
present/absent

ChiSquare/Logistic
Regression
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Population
The population selected for this investigation was patients who were hospitalized
with the diagnosis of ABSSSI with BSI who were admitted to one of the DMC hospitals
or HFH located within the city of Detroit. The DMC and HFH were chosen to collect
cases and controls for this investigation because this nine-hospital system has a centrally
located campus located in midtown Detroit and, therefore, services a large section of the
inner city Detroit patient population. Cases that were included in this study consisted of
patients admitted to the DMC and HFH with BSI whom developed within 48 hours of
admission and whom had ABSSSI identified as the primary infection source. Study
controls consisted of patients who were admitted to the DMC and HFH with the
diagnosis of ABSSSI without BSI. Patients were excluded if they had the diagnosis of
burns, gangrene, animal or human bites, and osteomyelitis due to severe complications
associated with these infections. Both cases and control patients were identified using the
International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9CM] diagnostic codes via the DMC and HFH electronic medical records. The health care
records were used to establish the exposure history for each study participant
(Aschengrau, 2008). The DMC and HFH electronic medical records are detailed data
files that describe the patient’s characteristics, laboratory values, diagnosis, progress, and
patient outcome including discharge status.
Sample Selection
Consecutive cases and controls were selected from January 2010-December 2015
from the electronic patient chart database of the DMC and HFH urban campuses on the
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basis of ICD-9-CM diagnostic codes for ABSSSI and BSI. The time period of 20102015 to collect cases was selected because this period of time was consistent with the
most recent guidelines for the diagnosis and treatment of SSTIs; therefore, medical
practice with regards to ABSSSI would be current and consistent (Mistry et al., 2014;
Moran et al., 2013; Pulia et al., 2014). Patients admitted to the hospital with the
diagnosis of ABSSSI or ABSSSI with BSI within 48 hours of admission were considered
community-associated ABSSSI or ABSSSI with BSI (Lark et al., 2001; Lipsky, Tabak, et
al., 2010). Control cases were identified by ICD-9-CM diagnostic codes for SSTIs that
met the definition of ABSSSI (abscess, cellulitis, abscess with cellulitis, and wound
infection). Cases were identified by ICD-9-CM diagnostic codes for BSI for which
ABSSSI had been identified as the source infection for BSI. Only community-associated
ABSSSI was included in this investigation because the primary objective of this study
was to evaluate the risk for BSI among individuals with ABSSSI from the urban
community of Detroit. Therefore, chronic SSSI including decubitus ulcers, hospitalderived SSSI secondary to surgical wounds, gangrene, amputation, and medical devices
were not included (Ray et al., 2013a). Community-associated infection was defined as
ABSSSI on hospital admission. Community-associated ABSSSI with concomitant BSI
was defined as individuals who had ABSSSI with BSI on admission or who developed
BSI within 48 hours of hospital admission and for which the treating physicians had
documented that ABSSSI was the source of the BSI (Lipsky, Kollef, et al., 2010; Tattevin
et al., 2012). Patients with SSTIs with the diagnosis of necrotizing fasciitis, pyomyositis,
burns, or ABSSSI secondary to recent surgery were excluded because these infections
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required immediate surgical intervention or had a high likelihood of poor patient
outcomes irrespective of concomitant BSI (Micek et al., 2010).
Procedures for Data Access
Access to the medical records of the DMC for the inclusion of cases and controls
was obtained via an application to the DMC Research Committee. A separate application
was made to the HFH Institutional Review Board (IRB). The application included the
detailed study protocol, data collection forms, and a description of the number of patients
as well as the specifics on patient data that were collected. Once the DMC research
application was approved, an IRB application approval was obtained from Walden
University and subsequently from Wayne State University, which served as the IRB for
Wayne State University and the DMC. Upon receiving permission to collect data from
the DMC and IRB approvals from Walden University, Wayne State University, and
HFH, data collection began. All data were de-identified to protect the personal
information of the participants. Participant data were collected via Internet passwordprotected data collection software.
Sample Size
The study population consisted of patients from the DMC urban campus hospitals
Detroit Receiving Hospital, Harper University Hospital and Sinai-Grace Hospital, and
HFH who were diagnosed with ABSSSI or ABSSSI with BSI. The minimum sample
size for an unmatched case-control study was calculated using the statistical test for
differences in proportions(Fleiss, 2003) as follows:
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r + 1 ( p )(1 − p )(Z β + Zα/2 )
n=(
)
r
(p1 − p2 ) 2

n = sample size in the case group
r + 1/r = ratio of controls to cases
( p ) (1 - p ) = a measure of variability (similar to standard deviation)
Zβ = represents the desired power (typically 0.84 for 80% power)
Zα/2 = represents the desired level of statistical significance (typically 1.96)
(p1 – p2) = effect size (the difference in proportions)
I used a sample size calculation OpenEpi with 1:1 for cases and controls to
determine a sample size requirement of 187 cases and 187 controls (total sample of 374)
to reach a power of 0.80 using a 2-sided significance level (1-α) of 0.05 to detect an
adjusted odds ratio of 2.0 (least extreme OR to be detected) for a factor with a known
prevalence of 10-20% (diabetes, renal failure, prior antibiotics, recurrent infection;
Carratala et al., 2003; Lark et al., 2001; Micek et al., 2010; OpenEpi, 2015). Regarding
my ability to meet the sample size requirement, I previously described the treatment of
over 300 patients meeting the definition of ABSSSI infection from a single DMC hospital
over a 2-year period (2012-2014; Claeys et al., 2015). Therefore, I was confident that I
could meet the sample size requirement because I proposed to collect cases from multiple
DMC hospital and HFH sites over an extended 5-year period.
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Operationalization
Variable Definitions
1.

Race/ethnicity was designated as listed in the patient’s medical chart and
was defined as categorical variables as the following: African American,
referent group, was compared to European American, Hispanic American,
and other racial/ethnic groups.

2.

Gender was recorded as listed in the patient’s medical chart and was
defined as a categorical variable as male or female.

3.

Age was measured in years (mean+/- standard deviation years) and was
collected from the patient’s medical chart and defined as a continuous
variable.

4.

Education was derived from the medical chart and was defined as a
categorical variable as < high school, high school graduate, college
graduate, and graduate school graduate.

5.

Income was derived from the Census Bureau of Statistics by the patient’s
zip code (i.e., average yearly household income within zip code).

6.

Insurance status was collected from the medical chart and was defined as a
dichotomous variable as present or absent.

7.

Comorbid conditions were derived from the medical chart and were
defined as dichotomous variables: diabetes; with or without end organ
damage; present or absent, chronic renal failure defined as creatinine
clearance < 30 ml/min or receiving renal dialysis; present or absent,
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cardiovascular disease; present or absent, intravenous drug use; present or
absent, hepatic disease; present or absent, paraplegia; present or absent,
HIV/AIDs; present or absent, use of steroids equivalent to prednisone 20
mg per day; present or absent and chemotherapy or radiation (within 30
days of hospital admission; present or absent.
8.

Charlson comorbidity index score was derived from the patient’s chart and
was defined as a continuous variable.

9.

Temperature and white blood cell count (WBC) was derived from the
patient’s medical chart and was defined as continuous variables as
temperature < 35.60C or > 38.00 C, or 35.6-38.00C and WBC > 11 x 109
cells/L.

10.

History of recent hospitalization was collected from the medical chart and
was defined within the last 180 days of the current hospitalization. These
data were treated as a dichotomous variable (recent hospitalization present
or absent).

11.

History of recent hospitalization of MRSA or MSSA infection (within the
last 60 days) was collected from the medical chart and was treated as a
dichotomous variable (recent MRSA or MSSA infection present or
absent).

12.

History of ABSSSI within the last 60 days was defined as a categorical
variable: present or absent.
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13.

Recent antibiotic exposure within the last 30 days was collected from the
medical chart and was treated as a dichotomous variable (antibiotic
exposure–present or absent).

14.

Type of antibiotic exposure (antibiotic class) within the last 30 days was
collected from the medical chart and was treated as a dichotomous
variable: present or absent.

15.

Location prior to hospital admission was derived from the patient’s
medical chart and was defined as community, other hospital, skilled
nursing facility, rehabilitation center, or other long-term care facility and
was treated as a categorical variable: present or absent.

16.

Length of hospital stay (days) was defined as a continuous variable.

17.

Surgical intervention an indicator of disease severity was collected from
the medical chart and was defined as dichotomous variable as surgical
intervention– incision and drainage, debridement, or amputation: present
or absent.

18.

Admission to the intensive care unit was defined as a dichotomous
variable: present or absent.

19.

Length of stay (days) in the intensive care unit was defined as a
continuous variable.

20.

Type of ABSSSI was defined as abscess, cellulitis, abscess and cellulitis,
infected wounds, and infections related to medical devices; type of
ABSSSI was defined as dichotomous variables: present or absent.
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21.

Presence of polymicrobial pathogens was defined as a dichotomous
variable: present or absent.

22.

Type of organism cultured from infected skin or wound was defined as
dichotomous variables as MSSA, MRSA, Streptococcus pyogenes, other
staphylococci species, other streptococci species, Corynebacterium,
anaerobes (i.e., clostridium), or Gram-negative organisms: present or
absent.

23.

Date of onset and clearance of bloodstream infection (days) was defined
as a continuous variable.

24.

Date of source control including drainage, wound debridement, and
medical device removal was defined as a continuous variable.

25.

Staphylococcus aureus cultured from bloodstream was defined as a
dichotomous variable: present or absent.

26.

Empiric and definitive (based on culture results) antibiotic therapy was
defined as dichotomous variables as empiric vancomycin, clindamycin IV
or PO, ampicillin/sulbactam, trimethoprim/sulfamethoxazole PO, other
definitive therapy vancomycin, daptomycin linezolid IV or PO,
ceftaroline, trimethoprim/sulfamethoxazole, clindamycin IV or PO, or
piperacillin/tazobactam or other: present or absent.

27.

Duration of inpatient antibiotics (days) was defined as a continuous
variable.
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28.

Clinical outcome at discharge was defined as a dichotomous variable as
alive, on antibiotics, alive, off antibiotics, left against medical advice
(AMA), or deceased: present or absent.

29.

Development of complications secondary to ABSSSI infection was
defined as a dichotomous variable: present or absent.

30.

Development of complications secondary to ABSSSI infection was
defined as dichotomous variables as endocarditis, nonvertebral
osteomyelitis, vertebral osteomyelitis, or other metastatic sites of
infection: present or absent.

31.

Reinfection within 30 days was defined as a dichotomous variable: present
or absent.

32.

Thirty day follow-up status was defined as dichotomous variables as
deceased, alive, no readmission, readmission, infection related,
readmission, non-infection-related, or other: present or absent.

33.

ABSSSI-associated BSI was the primary dependent outcome variable and
was determined via diagnosis verified in the patient’s medical chart.
ABSSSI-associated BSI was defined as individuals who had ABSSSI with
BSI on admission or who developed BSI within 48 hours of hospital
admission and for which the treating physicians had documented ABSSSI
as the source of the BSI.

34.

Final clinical outcome was defined as dichotomous variables as success
with all symptoms resolved and no need for further antibiotics, improved
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with some symptoms remaining and requiring further antibiotics and
failure, symptoms remaining or change in antibiotics, or need for further
surgical intervention.
Data Analysis Plan
Patient characteristics for cases and control patients were collected using the
password-protected RedCap® data collection software, which is a comprehensive
research data management system created by Vanderbilt University and hosted by Wayne
State University. The online data collection tool included the patient’s coded identifier
number, demographics such as age and gender, vital signs, patient underlying conditions
including comorbidities, location prior to hospital admission, laboratory values, and
ABSSSI and BSI diagnosis. Data analysis was conducted using SPSS Statistics (Version
23.0, Armonk, NY: IBM Corp.). Data entered into RedCap® can be downloaded
directly into SPSS. Data cleaning consisted of routine data analysis of the database for a
variety of potential errors including missing responses, typing and coding errors, removal
of duplicate data, removing spaces, and fixing dates and times. Data checks also
included evaluating the database for data that were out of range, inconsistent, or had
extreme values. Any missing values were treated to minimize their impact by assigning a
suitable value or discarding them using a methodically decision process (e.g., case or pair
wise deletion). This study had the following research questions: Are there significant
differences in clinical and socioeconomic factors between patients with ABSSSI and
ABSSSI with BSI in intercity Detroit? Is race/ethnicity associated with disease severity
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(based on surgical interventions [e.g., incision and drainage, wound debridement,
amputation]) among patients with ABSSSI-related BSI?
With respect to data analysis, descriptive statistics was used to characterize cases
and controls. Continuous variables were compared by Student t test if normally
distributed and Mann-Whitney U test if the normality assumption is not met. Categorical
variables were evaluated using Pearson’s chi-square test or, as necessary, a two-tailed
Fisher’s exact test. Regarding Research Hypothesis 1, patients with ABSSSI had
different sociodemographic and clinical factors compared to patients with ABSSSIassociated BSI, the relationship between sociodemographic and clinical factors and the
development of BSI was first examined using bivariate tests such as chi-square for
categorical variables with Yates’ correction where appropriate and Student independent ttest for continuous variables. All variables with a p value of < 0.1 in the unadjusted
analyses were included in a multivariable logistic model, which controls for confounding
variables (Bursac, Gauss, Williams, & Hosmer, 2008). A backwards-stepwise
elimination approach was used to eliminate the variable with the largest p value at each
step. The Hosmer-Lemeshow statistic was used to evaluate the predicted and observed
probability to test for evidence of a lack of a model fit (Paul, Pennell, & Lemeshow,
2013). Relationships between the predictor variables (e.g., race/ethnicity; comorbid
conditions such as renal failure, diabetes, and cardiovascular disease etc.) and BSI were
evaluated using the odds ratio and corresponding 95% confidence interval.
Research Question 2 was designed to examine whether race/ethnicity is associated
with disease severity (based upon surgical interventions [ e.g., incision and drainage,
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wound debridement, amputation]). The impact of race/ethnicity on severity was
evaluated using multivariable logistic regression. Bivariate analysis was performed
initially. All variables with a p value < 0.1 from the unadjusted analyses were included in
the logistic model. A backwards-stepwise elimination approach was used to eliminate
the variable with the largest p value at each step(Bursac et al., 2008). The HosmerLemeshow statistic was used to compare the predicted versus observed values to test the
goodness of fit (Paul et al., 2013). The results for Research Question 2 were evaluated
using the odds ratio and the 95% confidence interval. For all analyses, a p value of <
0.05 was considered to be statistically significant.
Threats to Validity
Both internal and external threats to validity may affect the study results. Internal
threats include misclassification, which is also referred to as a measurement error, could
be a threat to the study validity. Misclassification can occur in the classification of the
exposure or the disease (Aschengrau, 2008). In this investigation, comorbid conditions
and the severity of the conditions such as diabetes, renal failure, and cardiovascular
disease (exposure) had the potential for misclassification as these conditions were often
documented via patient history at the time of admission. In addition, misclassification of
BSI (disease) was possible because BSI could develop shortly after hospital admission
and not be recognized at baseline. In addition, it was possible that BSI could be recorded
as attributed to ABSSSI when the actual infection source was not detected during hospital
admission. With respect to BSI, the diagnosis of BSI was only considered when
diagnosed within 48 hours of admission and directly attributed to ABSSSI with no other
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likely source of infection. External validity threats included investigator interpretation of
the data including generalization of the data across different populations (Creswell,
2009). It was possible that the findings from the population of Detroit were unique and
not easily generalizable to different patient populations. It was also possible that
advancement in technologies including diagnostic techniques may reduce the significance
of these findings including the associations of patient risk and BSI. Every effort was
made in this study to accurately document underlying patient conditions and the
diagnosis of BSI to avoid exposure and disease misclassification.
Ethical Procedures
To ensure that the research met all human investigational compliance, the
research proposal was submitted to the Walden University IRB (IRB# 2-17-16 0303767);
Wayne State University’s IRB (IRB # 010616MIE; 12/14/15), which served as the IRB
for the DMC; and coordinating IRB for the Henry Ford Hospital IRB (IRB # 10245; 1-816). In addition, the research proposal was submitted to the DMC Research Committee
(DMC # 13730; 12/16/15) in order to gain access to the electronic medical record
database. An expedited approval was obtained with an informed consent waiver because
the study was a retrospective design. All data were de-identified to ensure patient
confidentiality, and HIPAA guidelines were followed to protect patient rights. Data were
collected on an Internet password electronic data collection form (RedCap®) developed
by Vanderbilt University and hosted by Wayne State University. The data will be
maintained for a period of 5 years and then will be destroyed.
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Summary
Research design, methods, plan for data access, sample size requirements, patient
population, and the planned data analysis were discussed in this chapter. Access to the
DMC electronic medical records was obtained through the DMC Research Committee.
Access to electronic medical records for Henry Ford Hospital was obtained from Henry
Ford Hospital’s IRB. In addition, the ethical procedures to protect patient rights were
described including IRB evaluation and approval and procedures for data protection. In
Chapter 4, I will review the purpose, research questions, and the hypotheses for this
investigation, along with a detailed description of the results including descriptive
statistics and the results of the bivariate and conditional logistic regression analysis.
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Chapter 4: Results
Introduction
The purpose of this case-control study was to identify the risk factors and health
outcomes of patients with low socioeconomic status in urban Detroit who had ABSSSIrelated Staphylococcus aureus BSI. The primary goal of this investigation was to
identify characteristics in patients with ABSSSI that were associated with the secondary
development of BSI. A secondary goal of this study was to evaluate the impact of race
and ethnicity on the severity of ABSSSI and ABSSSI-associated BSI. In this chapter, the
results are depicted starting with the study population descriptive analysis, followed by
the bivariate and multivariable analysis of the study variables.
Data Collection
A total of 5,267 electronic medical records from the DMC and HFH were
reviewed from January 2010 to December 2015. Patients with ABSSSI and ABSSSI
with BSI had to be diagnosed and admitted within 48 hours of admission to be considered
a community-acquired infection. Patients with necrotizing fasciitis, pyomysitis, burns,
gangrene, recent surgery, secondary to animal or human bites, and osteomyelitis were
excluded given that these infections can be life threatening, require immediate surgery,
and/or have nothing to do with risk factors or severity secondary to BSI. After these
exclusions, 392 patients met the study criteria for inclusion.
The study population of 392 patients consisted of 196 cases (ABSSSI + BSI) and
196 controls (ABSSSI) with a median age of 47 years (range 18-96 yrs.) and a male
predominance of 59.2% (see Table 3). Based on the sample size of 392 collected in this
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study, the minimum sample size of 374 was exceeded to reach a power of 0.8 for a 2sided significance level of 0.05 to detect an adjusted OR of 2.0 for a risk factor with a
known prevalence of 10-20% as stated in Chapter 3. With respect to race, African
Americans made up the majority of the study population at 56.1% followed by
European Americans at 37.2%, other race/ethnicities at 6.1%, and Asian Americans
0.5%. The most common type of ABSSSI was abscess plus cellulitis accounting for
39.8% of the subjects followed by abscess with 33.2% cases, cellulitis 19.4%, infected
wound 7.1%, and ulcers contributing to 0.5% of cases. In terms of sociodemographic
characteristics by zip code, 6.9% had less than a high school education, 35.7% were
considered below the federal poverty level in terms of income, and 19.1% had no medical
insurance. Figure 1 displays the cases and control distribution per zip code for Detroit
and non-Detroit areas.
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Table 3
Demographic and Clinical Characteristics of Study Population, n = 392
Variable
Population
Age (yr.), mean, +/- (SD)
48.7 (17.4)
Gender, n, (%)
Male
232 (59.2)
Female
160 (40.8)
Race, n, (%)
African-American
220 (56.1)
Asian
2 (0.5)
Caucasian
146 (37.2)
Other
24 (6.1)
Sociodemographics by zip code, n, (%)
>30% < high school education
27 (6.9)
Below poverty level income
140 (35.7)
No Medical insurance, n, (%)
75 (19.1)
Type of ABSSSI, n, (%)
ABSSSI
130 (33.2)
Cellulitis
76 (19.4
ABSSSI + Cellulitis
156 (39.8)
Infected Wound
28 (7.1)
Ulcer
2 (0.5)
2
BMI kg/m > 30, n, (%)
170 (43.4)
Staphylococcus aureus BSI, n, (%)
Methicillin-susceptible
70 (17.9)
Methicillin-resistant
126 (32.1)
Note. Sociodemographic data < 30% high school education and below poverty level
income were derived per zip code from federal census data. Status of medical insurance
was obtained from the individual patient medical chart.
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Figure 1. Case and Control by Zip Code

Figure 1. Case and control by zip code. Upper panels depict various zip codes from
Detroit and non-Detroit areas from which cases and controls were derived. Bottom panel
displays cases and controls per Detroit zip codes. Red circles indicate zip codes where
higher rates of cases were observed
Results
Research Question 1 and Hypothesis
1.

Are there significant differences in sociodemographic and clinical factors
between patients with ABSSSI and patients with ABSSSI-associated
bacteremia in intercity Detroit?

Ho1: There are no differences in sociodemographic and clinical factors between
patients with ABSSSI and ABSSSI-associated BSI.
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Ha1: Patients with ABSSSI have different sociodemographic and clinical factors
compared to patients with ABSSSI-associated BSI
Data analysis by chi-square, Fisher’s exact test, or Student independent t-test, or
Mann Whitney U test—where appropriate—of demographic, sociodemographic, and
clinical characteristics for patients with ABSSSI with BSI and ABSSSI are listed in Table
4. Individuals with ABSSSI + BSI were significantly older (p< 0.001) and were
predominately male (p = 0.008) compared to those with ABSSSI. There were no
significant differences observed with respect to race or sociodemographic characteristics
by zip code such as education, median income levels including poverty, or the type or
presence of medical insurance. Individuals with ABSSSI + BSI had a higher percentage
of abnormal temperature, elevated WBC counts, and acute renal failure on hospital
admission (p< 0.001). In addition, individuals with ABSSSI + BSI had a higher
percentage of cellulitis and infected wounds or ulcers whereas individuals with ABSSSI
had a higher percentage of abscess or abscess in combination with cellulitis (p<0.001).
Figure 2 displays infection type for those with ABSSSI + BSI and ABSSSI. Although
there was no difference in the infection site (e.g., upper versus lower extremity, p =
0.930), individuals with ABSSSI tended to have a higher rate of methicillin-resistant S.
aureus (p = 0.004).
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Table 4
Demographics, Sociodemographic, and Clinical Characteristics of Cases and Controls
Variables

ABSSSI + BSI
n = 196
52.4 (18.4)

ABSSSI
n = 196
45.3 (15.5)

p Value

Age (yr.), mean+/-(SD)
< 0.001
Gender, n, (%)
0.008
Male
129 (65.8)
103 (52.6)
Female
67 (34)
93 (47.0
Race, n, (%)
0.520
African-American
112 (57.1)
108 (55.1)
Asian
1(0.5)
1 (0.5)
Caucasian
68 (34.7)
78 (39.8)
Other
15 (7.7)
9 (4.6)
Sociodemographics by zip code, n, (%)
Education >30% No High School
18 (9.2)
9 (9.6)
0.073
Median Income < poverty
78 (39.8)
62 (31.6)
0.092
Medical Insurance, n, (%)
39 (19.9)
36 (18.4)
0.399
2
BMI>30 kg/m , n, (%)
79 (41.6)
91 (46.4)
0.340
Abnormal Temperature, n, (%)
87 (44.4)
38 (19.4)
<0.001
Elevated WBC, n, (%)
138 (60.3)
91 (39.7)
<0.001
Acute Renal Failure, n (%)
98 (50)
48 (24.5)
<0.001
Type of ABSSSI, n (%)
<0.001
Abscess
56 (28.6)
74 (37.8)
Cellulitis
56 (28.6)
20 (10.2)
Abscess + Cellulitis
58 (29.6)
98 (50)
Infected Wound
24 (12.2)
4 (2)
Ulcer
2 (1)
0 (0)
Infection Site, n, (%)
0.930
Upper Extremity
46 (23.5)
65 (33.2)
Lower Extremity
84 (42.9)
83 (42.3)
Head/Neck
31 (15.9)
20 (10.2)
Torso/Trunk
35 (17.9)
28 (14.3)
Methicillin-Resistant S. aureus, n, (%)
126 (64.3)
152 (77.7)
0.004
Polymicrobial, n, (%)
21 (10.8)
22 (11.2)
0.886
Note. Chi-square/Fisher’s exact test was used for categorical variables, and MannWhitney U test for continuous variables.
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Comorbid underlying conditions, patient characteristics, and clinical outcomes are
listed in Table 5. As can be seen by the Charlson comorbidity index median and IQR,
individuals with ABSSSI + BSI tended to have a higher number of underlying conditions
such as chronic renal failure and diabetes that were associated with 1-year mortality
compared to individuals with ABSSSI (p< 0.001). The distribution of comorbid
conditions between ABSSSI + BSI and ABSSSI are depicted in Figure 3. The most
common underlying conditions were diabetes, hypertension, and intravenous drug use.
Of interest, these three conditions were significantly (p = 0.003, p = 0.007, p = 0.012,
respectively) higher in patients with ABSSSI + BSI. In addition, there were significantly
more patients with ABSSSI + BSI who had previous hospitalization within 180 days of
hospital admission (p < 0.001) and who had a prior infection with methicillin-susceptible
S. aureus within 60 days of hospital admission (p = 0.014). There were also a higher
percentage of patients with ABSSSI + BSI who had an infectious diseases consult, were
admitted to the intensive care unit, and experienced a longer hospital stay (p < 0.001). In
addition, patients with ABSSSI + BSI had an increased hospital mortality (p < 0.001), a
higher clinical failure rate at discharge (p = 0.003), more surgical complications such as
incision and drainage at bedside (p < 0.001), and a higher amount of reinfection within 30
days of hospital discharge (p = 0.006). Antibiotic treatment for ABSSSI and BSI and
ABSSSI is depicted in Figure 4. Vancomycin was the most commonly used antibiotic
overall. Of interest, a significantly (p = 0.001) higher percentage of patients with
ABSSSI + BSI were treated with vancomycin compared to those with ABSSSI (79.1
versus 64.3%). Clindamycin was the second most common antibiotic administered.
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Although the use of clindamycin was higher in patients with ABSSSI (27 versus 18.9%),
this difference was not statistically significant (p = 0.055). While cephalexin use was
significantly (p= 0.030) higher in patients with ABSSSI, the overall use was low (6
versus 0, respectively).
Table 5
Comorbid Conditions, Patient Characteristics, and Clinical Outcomes
Variable
ABSSSI + BSI ABSSSI
p Value
Comorbid Conditions
Chronic Renal Failure, n, (%)
25 (12.9)
8 (4.1)
0.002
Hepatic Disease, n, (%)
18 (9.2)
4 (2.6)
0.005
Diabetes, n, (%)
76 (38.8)
49 (25.0)
0.003
Paraplegia, n, (%)
4 (2)
0 (0)
0.440
Hypertension, n, (%)
88 (44.9)
62 (31.6)
0.007
Congestive Heart Failure, n, (%)
19 (9.7)
7 (3.6)
0.015
IV Drug Use, n, (%)
44 (22.4)
25 (12.8)
0.012
Charlson Comorbidity Index, median, (IQR)
2 (1-5)
1 (0-3)
<0.001
Corticosteroids, n, (%)
2 (1)
1 (0.5)
0.562
Prior hospitalization 180 days, n, (%)
63 (32.1)
25 (12.8)
<0.001
Prior antibiotic use past 30 days, n (%)
18 (9.2)
16 (8.2)
0.720
Prior MSSA infection 60 days, n, (%)
6 (3.1)
0 (0)
0.014
Prior MRSA infection 60 days, n, (%)
11 (5.6)
7 (3.6)
0.334
History of ABSSSI past 60 days, n, (%)
22 (11.2)
14 (7.1)
0.162
Clinical Outcomes
ID Consult
115 (5.7)
54 (27.7)
<0.001
Admission to ICU, n, (%)
25 (12.8)
5 (2.6)
<0.001
Length of hospital stay, (d), mean, (SD)
7.4 (5.7)
2.7 (2.2)
<0.001
Clinical failure at discharge, n, (%)
22 (11.3)
7 (3.6)
0.003
In hospital mortality, n (%)
8 (4.1)
0 (0)
<0.001
Complications, n (%)
7 (3.6)
1 (0.5)
0.034
Surgery, n, (%)
106 (54.1)
118 (60.5)
0.199
Incision and drainage at bedside, n, (%)
37 (18.9)
88 (44.9)
<0.001
Incision and drainage at OR, n (%)
68 (34.7)
76 (38.8)
0.402
Wound debridement, n (%)
9 (4.6)
6 (3.1)
0.300
Re-infection within 30 days, n, (%)
22 (11.2)
8 (4.1)
0.006
Note. The Charlson Comorbidity Index predicts the one-year mortality for a patient with a
range of comorbid conditions. Chi-square or Fisher’s Exact test was used for categorical
variables and Mann-Whitney U test was used to analyze continuous variables.
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Figure 2. Infec.on Site
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Figure 2. Infection type comparisons between ABSSSI + BSI and ABSSSI.

Figure 3. Comparison of comorbidities for ABSSSI + BSI and ABSSSI patients.
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Figure 4. Antibiotic Treatment

Figure 4. Comparison of antibiotic treatment for ABSSSI + BSI versus ABSSSI patients.
Table 6 displays the results of the logistic regression analysis of all demographic,
sociodemographic, and clinical characteristics that met the minimal p value of < 0.1 via
bivariate analysis. According to the results from the logistic regression analysis, males
had higher odds of being ABSSSI + BSI than females; with an aOR of 1.85, 95% CI
1.11-3.66 had acute renal failure, aOR 2.08, 95% CI 1.18-3.67 (p = 0.011), and abused
intravenous drugs, aOR 4.38, 2.22-8.62 (P < 0.001). Additional risk variables that
remained in the model and were significant for ABSSSI +BSI included prior
hospitalization within 180 days of hospital admission with an aOR of 2.41, 95% CI 1.244.93 (p = 0.01); abnormal temperature, aOR 2.86, 95% CI 1.66-4.93 (p < 0.001); and,
elevated WBC count, aOR 4.26, 95% CI 2.43-7.47 (p < 0.001) compared to individuals
with ABSSSI. Compared to ABSSSI + BSI, individuals who had ABSSSI and abscess or
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abscess and cellulitis were protected from bloodstream infection with an aOR of 0.220,
95% CI 0.11-0.46 and aOR 0.139, 95% CI 0.07-0.28 (p < 0.001), respectively. The
Hosmer-Lemeshow goodness of fit test was not significant (p = 0.305) indicating that
there was no evidence of a lack of model fit. On the basis of these findings, Research
Question 1 hypothesis was rejected, and the alternative hypothesis was accepted
indicating that patients with ABSSSI-associated BSIs had significant differences in
sociodemographic and clinical factors compared to patients with ABSSSI.
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Table 6
Logistic Regression Analysis of Patient Risk Factors for ABSSSI+BSI
Factor

Unadjusted OR

95%
Confidence
Interval
1.16-2.61
0.92-4.80

Adjusted OR

95%
Confidence
Interval
1.11-3.66
0.98-8.64

Sex (Male)
1.74
1.85
High School >30% < HS by
2.10
2.91
Zip Code
Acute Renal Failure
3.08
2.0-4.74
2.08
1.18-3.66
IV Drug Use
1.98
1.16-3.39
4.38
2.22-8.62
Charlson Comorbidity Index
1.29
1.18-1.42
1.13
0.99-1.28
Prior Hospitalization within
3.24
1.93-5.43
2.41
1.24-4.70
180 days
Abnormal Temperature
3.25
2.07
2.86
1.66-4.93
Elevated WBC
2.75
1.81-4.16
4.26
2.43-7.47
Abscess
0.659
0.432-1.01
0.220
0.11-0.46
Abscess + Cellulitis
0.420
0.28-0.64
0.139
0.07-0.28
Hosmer-Lemeshow p = 0.305
Note. High school > 30% <HS by zip code= indicates a zip code where >30% of population of
has not completed high school, Charlson comorbidity index predicts the 1-year mortality for a
patient with a range of comorbid conditions, abnormal temperature = temperature > or < 98.60 F,
elevated WBC = WBC count > 11 x 109 cells/liter. Referent group for the following covariates
are listed here: male versus female, high school < 30% by zip code versus all other zip codes,
acute renal failure versus no renal failure, IV drug use versus no drug use, Charlson comorbidity
index; individuals grouped by scores (0-4 and > 4) referent group < 4, prior hospitalization
within 180 days versus no hospitalization, abnormal normal temperature and elevated WBC
versus normal temperature and WBC, abscess or abscess + cellulitis versus all other types of
infection.
Research Question 2 and Hypothesis
2.

Is race/ethnicity associated with disease severity (based upon surgical
interventions [e.g., incision and drainage, wound debridement,
amputation, shock or admission to the ICU]) among ABSSSI-associated
BSI?
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H02: Race/ethnicity is not associated disease severity (based upon surgical
interventions [e.g., incision and drainage, wound debridement, amputation, shock, or
admission to the ICU]) among patients with ABSSSI-associated BSI.
Ha2: Race/ethnicity is associated with disease severity (based upon surgical
interventions [e.g., incision and drainage, wound debridement, amputation, shock, or
admission to the ICU]) among patients with ABSSSI-associated BSI.
The second research question in this study was designed to evaluate whether race
and ethnicity had an impact on the severity of diseases. Analysis of this question by
bivariate analysis using chi-square or Fisher’s exact test for categorical variables and
Mann-Whitney U test for continuous variables is displayed in Table 7. I found that,
compared to all other race/ethnicities, African Americans had a higher percentage (66.9
versus 48.3%, p<0.001) of severe disease versus nonsevere disease, whereas individuals
who were European American had a low rate of severe disease (47 versus 99%, p =
0.002) compared to other race/ethnicities.
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Table 7
Demographic, Sociodemographic, and Clinical Characteristics by Severity
Variables

Nonsevere
n = 226
48.5 (18.1)

Severe
n = 166
49.3 (16.2)

p Value

Age (yr.), mean+/-(SD)
0.645
Gender, n, (%)
0.213
Male
140 (61.9)
92 (55.4)
Female
86 (38.1)
74 (44.6
Race, n, (%)
African-American
109 (48.3)
111 (66.9)
<0.001
Asian
2(0.9)
0 (0.0)
0.510
Caucasian
99 (43.2)
47 (28.3)
0.002
Other
16 (7.1)
8 (4.8)
0.401
Sociodemographics by zip code, n, (%)
Education >30% No High School
18 (8.0)
9 (5.4)
0.420
Median Income < poverty
85 (37.6)
55 (33.1)
0.394
Medical Insurance, n, (%)
42 (18.6)
33 (18.9)
0.795
BMI>30 kg/m2, n, (%)
93 (41.7)
77 (47.2)
0.300
Abnormal Temperature, n, (%)
62 (27.4)
62 (37.3)
0.024
Elevated WBC, n, (%)
113 (50.0)
116 (69.9)
<0.001
Acute Renal Failure, n (%)
73(32.3)
73 (44.0)
0.012
Type of ABSSSI, n (%)
Abscess
75 (33.26)
55 (33.1)
0.540
Cellulitis
66 (29.2)
10 (6.0)
<0.001
Abscess + Cellulitis
73 (32.3)
83 (50)
<0.001
Infected Wound
12.0 (5.3)
16 (9.6)
0.114
Ulcer
0.0 (0.0)
2 (1.2)
0.179
Infection Site, n, (%)
0.400
Upper Extremity
69 (30.5)
42 (25.3)
Lower Extremity
93 (41.2)
74 (44.6)
Head/Neck
32 (14.2)
19 (11.4)
Torso/Trunk
32 (14.2)
31 (18.7)
Methicillin-Resistant S. aureus, n, (%)
156 (69.0)
122 (73.5)
0.369
Polymicrobial, n, (%)
19 (8.4)
24 (14.5)
0.071
Comorbidities
Chronic Renal Failure, n, (%)
16 (7.1)
17 (10.2)
0.265
Hepatic Disease, n, (%)
15 (6.6)
8 (4.8)
0.519
Diabetes, n, (%)
67 (29.6)
58 (34.9)
0.266
Paraplegia, n, (%)
1 (0.4)
3 (1.8)
0.315
Hypertension, n, (%)
79 (35.0)
62 (31.6)
0.116
Congestive Heart Failure, n, (%)
12 (5.5)
14 (8.4)
0.226
IV Drug Use, n, (%)
37 (16.4)
32 (19.3)
0.455
Charlson Comorbidity Indexa, median, (IQR)
2 (0-4)
2 (1-5)
0.369
Corticosteroids, n, (%)
1 (0.4)
2 (1.2)
0.576
Prior hospitalization 180 days, n, (%)
63 (32.1)
45 (27.1)
0.058
Prior antibiotic use past 30 days, n (%)
14 (6.2)
20 (12.0)
0.042
Prior MSSA infection 60 days, n, (%)
6 (2.7)
12 (7.2)
0.408
Prior MRSA infection 60 days, n, (%)
11 (5.6)
7 (3.6)
0.033
History of ABSSSI past 60 days, n,(%)
16 (7.1)
20 (12.0)
0.092
Note. The Charlson comorbidity index predicts the one-year mortality for a patient with a range of comorbid
conditions.
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Table 8 displays the results of the logistic regression analysis of ABSSSI + BSI
and ABSSSI patient risk factors by severity. After controlling for confounding variables,
African American race and elevated WBC count remained in the model and were
significantly (p=0.001) associated with severe infection, aOR 2.18, 95% CI; 1.38-3.4 and
aOR 2.24, 95% CI; 1.41-3.55, respectfully. In addition, prior hospitalization within 180
days of admission was also significantly (p=0.010) associated with severe disease, aOR,
2.07, 95% CI; 1.19-3. Although renal failure and polymicrobial ABSSSI had an
increased association with severe infection (i.e., with aOR of 2.26, 95% CI; 0.932-5.5 and
aOR of 1.87, 95% CI; 0.930-3.74), these were not statistically significant (p=0.071,
0.079). On the basis of these findings, Research Question 2 and Hypothesis 2 was
rejected, and the alternative hypothesis was accepted indicating that race/ethnicity was
associated with disease severity (based upon surgical interventions [e.g., incision and
drainage, wound debridement, amputation, shock, or admission to the ICU]) among
patients with ABSSSI-associated bloodstream infections.
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Table 8
Logistic Regression Analysis of Patient Risk Factors by Severity
Factor

Unadjusted OR 95%
Confidence
Interval
2.17
1.43-3.28
2.32
1.52-4.5
1.50
0.73-3.06
0.155
0.087-0.31
3.0
1.39-3.17
1.84
0.97-3.49
1.58
0.98-2.56

Adjusted
OR

95% Confidence
Interval

African American
2.18
1.38-3.44
Elevated WBC
2.24
1.41-3.55
Acute Renal Failure
2.26
0.932-5.49
Cellulitis
0.202
0.92-0.44
Abscess + Cellulitis
1.65
1.03-2.65
Polymicrobial
1.86
0.930-3.74
Prior Hospitalization
2.07
1.193-3.59
180 days
Hosmer-Lemeshow p = 0.843
Note. Referent groups for the following covariates are listed here: African Americans
versus all other races, elevated WBC > 11 x 109 cells/ L versus < 11 x 109 cells/L, acute
renal failure versus no renal failure, cellulitis and abscess + cellulitis versus all other skin
infection types, polymicrobial infection versus all other types of infection, prior
hospitalization 180 days versus no infection.
Summary
In Chapter 4, I provided an overview of the data results analyzed for this research
investigation. With regards to the first research question on whether sociodemographic
and clinical factors differed between patients with ABSSSI + BSI and ABSSSI, I found
that there were several factors that were associated with ABSSSI + BSI including the
presence of acute renal failure, a history of intravenous drug use or prior hospitalization,
and abnormal temperature and elevated WBC count. ABSSSI that was classified as
abscess or abscess plus cellulitis appeared to be protective. With regards to the second
research question on whether race and ethnicity was associated with severity of disease,
African Americans were more likely to have a more severe disease. An elevated WBC
count on admission, a history of prior hospitalization, and the diagnosis of abscess +

78
cellulitis were also associated with severe disease. In Chapter 5, I will provide an indepth discussion of the results and their implications as well as concluding statements,
intervention recommendations, and the impact of these findings on social change.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this investigation was to determine the risk factors that were
associated with patients who had Staphylococcus aureus ABSSSI with BSI versus
individuals who had ABSSSI without BSI from the city of Detroit. The study design was
a case control retrospective evaluation. Data collection consisted of evaluating electronic
medical charts from two medical centers from January 2010 until December 2015. The
DMC and HFH are major medical centers located in downtown Detroit that serve the
population of Detroit as well as the surrounding Detroit Metropolitan areas. ABSSSI +
BSI (cases) were defined as an individual who had ABSSSI + BSI with BSI diagnosed
within 48 hours of hospital admission. Individuals with ABSSSI but without BSI served
as the study controls (Lipsky, Kollef, et al., 2010). Overall, 392 patients (196 cases, 196
controls) who were diagnosed with ABSSSI + BSI and ABSSSI made up the study
population. Descriptive statistics and logistic regression models were used to analyze
Research Question 1 and 2 that dealt with the risk factors for ABSSSI + BSI as well as
determining the impact of race and ethnicity on the severity of disease. BSIs are
associated with serious complications including mortality. Evaluating risk factors that
maybe unique to the population of Detroit was important to identify potential cases early
and to direct optimized medical intervention to avoid these complications. In addition,
determining whether race and ethnicity had an impact on the severity of disease was
important because the city of Detroit has a predominant African American population,
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and this underserved population has been previously reported to have higher rates of
medical complications.
Interpretation of Findings
Research Question 1
The first research question was designed to determine if there were risk factors for
patients who had ABSSSI and acquired BSI who resided in intercity Detroit. This was
accomplished by determining if there were any significant differences in clinical or
socioeconomic factors between patients with ABSSSI and ABSSSI with BSI. Although
limited data exist, several researchers have examined the relationship between patient
characteristics and BSI in individuals with ABSSSI, which included the acquisition of
MRSA from the community (Tattevin et al., 2012), old age, male sex, coronary heart
disease, the presence of infected prosthetic devices, health care-associated infections,
abnormal WBC counts, and vital signs such as temperature (Lipsky, Kollef, et al., 2010).
However, these investigations included patients who acquired their infection in the
hospital, making it difficult to extrapolate these findings to community-acquired ABSSSI
with BSI. In addition, the contribution of socioeconomic factors was not examined. I
also found that older age, male gender, abnormal temperature, and elevated WBC count
on hospital admission was significantly associated with ABSSSI with BSI by descriptive
statistical analysis (Table 2). Other factors that were statistically significant for ABSSSI
with BSI was the presence of MRSA, prior hospitalization within the last 180 days, and
prior MSSA infection within the last 60 days. In addition, < 30% high school education
by zip code was significantly associated with ABSSSI with BSI. Although income and
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other sociodemographic characteristics had been previously evaluated for MRSA
infections, the relationship between education level and ABSSSI with BSI had not been
reported previously. In the present study, there were a number of comorbid conditions
(Table 3) that were found to be associated with ABSSSI with BSI such as acute and
chronic renal failure, hepatic disease, diabetes, hypertension, congestive heart failure, and
IV drug use. Several of these factors had been previously reported. However, these
scholars focused only on hospitalized patients and, therefore, the data may not be
generalizable to patients who derived BSI in the community (Lipsky, Kollef et al., 2010).
The number of comorbid conditions present on admission was significant for ABSSSI
with BSI and, though this relationship has not been previously reported, it may be useful
for predicting whether a patient may be at increased risk for ABSSSI with BSI. As
expected, a significantly higher percentage of patients with ABSSSI with BSI required an
infectious disease consult, were admitted to the ICU, deemed a failure at time of
discharge, and had a higher rate of mortality and reinfection within 30 days of discharge.
After adjusting for confounding variables in a logistic regression model (Table 4), male
sex, high school < 30% by zip code, acute renal failure, Charlson comorbidity index, IV
drug use, prior hospitalization within the last 180 days, abnormal temperature, and
elevated WBC were independent predictors of ABSSSI with BSI. Further, abscess or
abscess plus cellulitis appeared to have a protective effect (aOR 0.220, 0.139,
respectively). The most probable explanation for this protective effect may be related to
routine medical intervention that commonly includes surgical incision and drainage of the
abscess. In many cases, this removes the focus of the infection and, therefore, likely
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protects the patients from BSI as a complication of ABSSSI (Moran et al., 2013; Pollack,
et al., 2015; Stevens et al., 2014).
Research Question 2
In the second research question, I evaluated whether race/ethnicity was associated
with disease severity. A composite definition was used to define severity, which
consisted of incision and drainage in the operating room, wound debridement,
amputation, and admission to the ICU or shock with patients with ABSSSI or ABSSSIassociated BSI. African Americans have significantly higher rates of SSTIs compared to
European Americans (Ray et al., 2013a). In general, African Americans of low
socioeconomic status have a higher rate of persistent infection, higher readmission rates,
and increased infection complications (Acosta et al., 2013; Morris et al., 2014; Zajacova,
Dowd, & Aiello, 2009). However, the impact of ethnicity on severity of disease in
patients with ABSSSI and ABSSSI with BSI has not been evaluated.
In the current study, when the cohort was evaluated by bivariate analysis on the
basis of severity, African Americans had a significantly higher amount of cases classified
as severe (66.9 versus nonsevere 48.3%) while European Americans had a significantly
lower amount of cases classified as severe (28.3 versus 43.8%, respectively). Besides
having abnormal temperature and elevated WBC on admission, individuals with more
severe disease had a higher percentage of acute renal failure as well as a higher
percentage of cellulitis and abscess and prior antibiotic use in the past 30 days. When
evaluated by logistic regression controlling for potential confounding, African American
race, elevated WBC, the presence of abscess plus cellulitis, and prior hospitalization
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within the past 180 days remained in the model and had a significantly higher odds of
having more severe disease than other groups. Individuals diagnosed with cellulitis
without abscess had a significantly lower odds ratio (aOR 0.202) for severe disease,
which may indicate that cellulitis without abscess may have a protective effect.
Individuals with abscess are more likely to have surgical drainage as a part of their
treatment intervention. Surgical drainage removes the foci of infection and improves the
likelihood of antibiotic success (Moran et al., 2013; Pollack, 2015; Stevens, 2014). This
procedure likely prevents patients’ localized infection (abscess) from spreading into the
surrounding tissue causing cellulitis and potentially BSI. Individuals with abscess and
cellulitis already have an extensive infection that has spread into the surrounding tissues
and, thus are, more likely to acquire BSI.
Theoretical Framework
The theoretical framework that was chosen for this study was the web of
causation. Causation is the event or condition that leads to the outcome of interest. It
provides a mechanism that helps to explain the process that leads to the development of
disease. Preceding events or conditions lead to the outcome of interest (Kreiger, 1994).
Disease development can be related to a variety of factors including underlying genetic
abnormalities, microorganisms, environmental factors, and social and behavioral
characteristics (Norton, 2015). In the present study, the web of causation applied because
the mechanisms in which a patient with ABSSSI acquires BSI had not been defined.
Although BSI is known to be a severe complication of ABSSSI, the underlying patient
characteristics and conditions that lead to BSI are not known. Further, it is not known if
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sociodemographic conditions or race/ethnicity may contribute to the acquisition of BSI or
the severity of the disease. African-American race, diabetes, renal failure, hypertension,
congestive heart failure, intravenous drug use, prior MRSA infections, prior
hospitalization and antibiotic use are some of key risk factor findings in this study that
were linked to ABSSSI + BSI and severity of disease. Understanding the factors that
contribute to ABSSSI and ABSSSI with BSI—especially as it relates to a relatively
underserved population in the city of Detroit—is important for prevention and treatment
interventions that could avoid these complications.
Limitations of the Study
This study was a retrospective study design and, therefore, was subject to all of
the potential biases associated with this type of investigation. For example, it was
possible that there may be missing or incomplete data recorded in the medical charts.
While it appeared that incomplete or missing data was minimal during the data collection,
it is possible that some data was not recorded or was recorded incorrectly. Another
potential limitation was the assumption that in patients with the diagnosis of cellulitis and
BSI, the S. aureus identified in the bloodstream originated from the patient’s cellulitis.
Cellulitis is a deep-seated infection of the subcutaneous tissues of the skin and, thereby,
difficult to culture the pathogen causing disease. While S. aureus is a pathogen
associated with cellulitis, other bacterial pathogens such as streptococci are also a
frequent cause of cellulitis (Dryden, 2010; Stevens et al., 2014). Therefore, although
unlikely, cases of BSI where cellulitis without abscess was identified as the infection type
may have been misclassified. Additionally, I evaluated the impact of race and ethnicity
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on severity of disease. The composite definition for severity included amputation.
However, there were no amputations recorded in the population cohort. It was possible
that the exclusion of diabetic foot infections from this study may be the most likely
reason for the lack of amputations because surgical intervention including amputation is
common among this population. Further, one of the objectives of this investigation was
to determine whether sociodemographic characteristics were associated with ABSSSI
with BSI. However, this information was derived by zip code that was provided through
federal census data. Individual information on education and level of income was not
available on an individual basis; therefore, the information was limited. Lastly, the study
was conducted on a population of individuals who reside in Detroit or its immediate
surrounding areas. It is possible that the results of this investigation cannot be
extrapolated to other metropolitan populations.
Recommendations for Future Research
Although a number of potential risk factors that may be associated with ABSSSI
with BSI were identified in this investigation including race, additional research should
be explored elsewhere to confirm that race or access to medical care is the most likely
explanation for this finding. African Americans have been previously identified as at risk
for a number of infection related diseases and complications (Klevens, et al., 2007; Ray
et al., 2012). However, it is unclear whether this finding is related to race/ethnicity issues
or lower socioeconomic status in this population and, therefore, poor access to medical
care. Although < 30% high school education by zip code was significantly associated
with ABSSSI and BSI, level of income was not. It was possible that the measurement of
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these factors by zip code may not be sensitive enough to delineate a relationship between
sociodemographic characteristics and ABSSSI with BSI. Future research investigating
the relationship between ABSSSI with BSI and sociodemographic factors should evaluate
this information on an individual basis. Understanding the relationship between
sociodemographic characteristics and complications of infection could lead to
interventions including risk assessment for disease development.
Recommendations for Future Action
In this study, I examined a population in urban Detroit Michigan at risk for
ABSSSI and ABSSSI with BSI. Although risk factors have been evaluated in patients
hospitalized for ABSSSI, there are limited studies on the risk for BSI in patients with
ABSSSI from the community (Lipsky, Kollef, et al., 2010). In addition, there are no
investigations on the risk for BSI in patients with ABSSSI from an urban environment
such as Detroit. It is important to evaluate intercity populations for disease risk for
infection because these populations often are of lower socioeconomic status and,
therefore, are at risk due to limited access to appropriate medical care (Khabbaz et al.,
2014; Lantz & Prichard, 2010). Individuals of lower socioeconomic status are more
likely to delay seeking medical attention and are at risk for increased complications
including hospitalization, surgery, relapse, and readmission (Acosta et al., 2013; Ray et
al., 2013a). A delay in seeking medical attention for ABSSSI can lead to the acquisition
of BSI with severe complications including mortality (Acosta et al., 2013; van Hal,
2012).
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Implications for Social Change
Patients with Staphylococcus aureus BSIs experience a high degree of
complications including metastatic spread leading to severe life threatening infections
(Corey, 2009; del Rio et al., 2009). If not appropriately and promptly treated, mortality
rates can range from 20-40% (Gould, 2007; Kobayashi, Yokota, Takahashi, Arioka &
Fukui, 2014). One of the most severe complications from ABSSSI is BSI. The burden of
infection is higher in non-Hispanic Blacks and Mexican Americans (Zajacova et al.,
2009). In addition, higher readmission rates, risk of infection, and sepsis have been
reported among African Americans (Acosta et al., 2013; Morris et al., 2014).
Understanding the characteristics and risks associated in patients with ABSSSI with BSI
is important to identify the most appropriate intervention to prevent and reduce these
complications. There is a need to direct medical resources and social support to
individuals in intercity Detroit who are at risk for ABSSSI and BSI. Partnerships
between community organizations, public health authorities, and intercity hospitals are
needed to educate, screen, and identify individuals at risk to prevent these infections in
this patient population.
Conclusion
The acquisition of BSI secondary to ABSSSI can be severe and include a variety
of complications such as spread of infection to other vital organs and tissues, sepsis, and
shock leading to death. Understanding the risk factors associated with BSI can lead to
preventive interventions to reduce complications including mortality. This is particularly
important in patient populations of low socioeconomic status because they have been
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demonstrated to have worse clinical outcomes. While this relationship has been
previously reported, there is little to no information in patients with low socioeconomic
status diagnosed with ABSSSI and BSI. Therefore, a knowledge gap existed regarding
this patient population and BSI secondary to ABSSSI. In this study, I identified a
number of patient characteristics, including sociodemographic factors such as level of
education, that may contribute to BSI in patients with ABSSSI. In addition, several
factors including African American race was associated with a higher degree of infection
severity. According to these findings, there is a need to include sociodemographic
characteristics when evaluating patient health outcomes. Further research is warranted to
more fully characterize these risks to prevent these complications in this vulnerable
patient population.
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